Beruflich Dokumente
Kultur Dokumente
Medical Protocols
Medical Protocols
The Galveston Area Ambulance Authority(GAAA) Treatment Protocols are for the sole use of providers
that are providing care under the authority of GAAA or while deployed by GAAA in a disaster situation.
These protocols are valid from March 1, 2017 through March 31, 2018.
The GAAA protocols were written using the guidance of medical research and following accepted
national standards. The protocols were written by a committee of practicing paramedics at GAAA after
lengthy research and debate. The protocols were approved by Dr. James Vincent, medical director for
GAAA. This document is based upon current accepted medical practice and evidence. Due to the
evolving nature of medical standards this document is not a static piece of paper but is expected to be
used and revised as a dynamic document.
These protocols are a tool that providers will use with their assessment, knowledge, and experience to
provide exceptional patient care. Protocols are not meant to be blindly followed; instead providers
should understand the rationale behind the protocol pathways. All pathways are to be utilized only to
the degree that the patient requires. The pathways in the flowchart are used to facilitate the most
appropriate level of care for the patient. If a patient’s status does not require a certain pathway, it is
acceptable to omit or skip the treatment. Protocols are written for specific sets of symptoms and
conditions and can be combined in order to address the patient’s needs and complaints. The committee
and the medical director at GAAA recognize that in certain circumstances deviation from the protocols is
in the best interest of the patient. Protocol deviations should be a rare event and require detailed
documentation.
GAAA services a large area of Galveston County with multiple providers of various certification and
licensure levels. GAAA also utilizes first responders in the majority of our response districts and provides
non-emergency and emergency transfers originating in Galveston County and surrounding areas. With
the exception of Beach Patrol providers who are trained in the use of blind airway devices and basic first
aid, these protocols are not meant to provide authorization for providers outside of the GAAA system.
Any questions regarding who can practice under these guidelines should be referred to GAAA SOGs.
Medical Director
January 1, 2017
I have been made aware of impending shortages of normal saline supplies, due to national shortages. In
the setting of limited supplies:
2. Lactated Ringers (LR) may be used as a substitute for NS throughout the protocols when
indicated. As LR may be detrimental to patients in a shock or hypoperfusion state, carefully
weigh the risks of aggressive LR use, versus holding fluids and/or optimizing transport time to
the hospital, in these patients.
James Vincent, MD
Medical Director
Fundamentals of Care
Patient Assessment 8
Documentation Guidelines 11
Specialty Care 17
Types of Consent 20
Treatment of Minors 21
Refusals 23
Termination of CPR 24
Hospice Patients 28
Scope of Practice 29
Inter-Facility Transfers 31
Ebola Preparedness 35
Universal Treatment
Failed Airway 42
Pain Management 43
Police Custody 44
Medical
Allergic Reaction 45
Anxiety 46
Behavioral Emergencies 47
Excited Delirium 48
COPD / Asthma 49
Diabetic Emergency 50
Hypotension 51
Nausea / Vomiting 52
Overdose 53
Respiratory Distress 54
Seizure 55
Stroke / CVA 56
Syncope 57
Cardiac
Supra-Ventricular Tachycardia 60
Symptomatic Bradycardia 63
Post Resuscitation 65
Hypertension 67
Trauma
Crush Injury 70
Major Trauma 71
Extremity Trauma 72
Burns – Thermal 75
Snake Bite 77
Pediatric
Active Labor 79
OB Emergencies 80
Neonatal Resuscitation 82
Pediatric Seizure 87
Pediatric Bradycardia 89
Procedures
Capnography 91
Child Birth 94
CPAP 95
Infection Control 98
Tourniquet 111
Venti-Pac 117
Paramedic Procedure-
See Protocol-
Patient Assessment
A systematic approach to patient assessment allows for high quality and safe care that will be consistent
between providers and across a wide variety of patient encounters. The following outlines the expected
framework for the assessment, treatment, and communication which should occur for EVERY patient
encounter:
Primary Survey
1. Airway - is it patent? Identify and correct existing or potential obstruction, inclusive of advanced
airway management as indicated.
2. Breathing - rate and quality. Identify and correct existing or potential compromising factors
3. Circulation – pulse, rate, quality, and location. Control external bleeding.
4. Determine level of consciousness (use AVPU system, Glasgow Coma Scale, or other system as
indicated).
Secondary Survey
Cardiac Monitoring
1. Patients experiencing possible cardiac symptoms must have a 12 lead EKG within 5 minutes of
patient contact whenever possible. Refer to the appropriate protocol for specific treatment.
(12 lead EKG is appropriate prior to and post administration of medications, tracings should be
attached to the e-PCR)
Indications for 12 Lead Monitoring
Chest Pain or discomfort (radiating or non-radiating)
Congestive Heart Failure (CHF)
Syncope or near Syncope
Unconscious
Respiratory distress in patients >18 years of age
Chest Trauma (blunt or penetrating)
Non Traumatic GI bleeding
Overdose
CVA and or HTN
Female >50 years presenting with abdominal arm or neck pain.
Hypertension or Hypotension
Altered Mental Status
Post Resuscitation
2. Rhythms, dysrhythmias and 12-lead EKG's are to be documented and recorded as part of the
patient’s record. A hard copy of the 12-lead EKG shall be made:
a. The 12 Lead ECG must be uploaded and attached to the patients ESO e-PCR when
possible.
b. If/when electronic attachment is not possible due to technology failure, a paper copy
must be made and routed to the Mid County Annex EMS office and filed in patient
records.
c. The 12 lead must include;
i. The call run number
ii. Patient name
iii. Age
iv. Date of service
v. Receiving hospital
Patient Assessment
A systematic approach to patient assessment allows for high quality and safe care that will be consistent
between providers and across a wide variety of patient encounters. The following outlines the expected
framework for the assessment, treatment, and communication which should occur for EVERY patient
encounter:
Primary Survey
1. Airway - is it patent? Identify and correct existing or potential obstruction, inclusive of advanced
airway management as indicated.
2. Breathing - rate and quality. Identify and correct existing or potential compromising factors
3. Circulation – pulse, rate, quality, and location. Control external bleeding.
4. Determine level of consciousness (use AVPU system, Glasgow Coma Scale, or other system as
indicated).
Secondary Survey
Cardiac Monitoring
1. Patients experiencing possible cardiac symptoms must have a 12 lead EKG within 5 minutes of
patient contact whenever possible. Refer to the appropriate protocol for specific treatment.
(12 lead EKG is appropriate prior to and post administration of medications, tracings should be
attached to the e-PCR)
Indications for 12 Lead Monitoring
Chest Pain or discomfort (radiating or non-radiating)
Congestive Heart Failure (CHF)
Syncope or near Syncope
Unconscious
Respiratory distress in patients >18 years of age
Chest Trauma (blunt or penetrating)
Non Traumatic GI bleeding
Overdose
CVA and or HTN
Female >50 years presenting with abdominal arm or neck pain.
Hypertension or Hypotension
Altered Mental Status
Post Resuscitation
2. Rhythms, dysrhythmias and 12-lead EKG's are to be documented and recorded as part of the
patient’s record. A hard copy of the 12-lead EKG shall be made:
a. The 12 Lead ECG must be uploaded and attached to the patients ESO e-PCR when
possible.
b. If/when electronic attachment is not possible due to technology failure, a paper copy
must be made and routed to the Mid County Annex EMS office and filed in patient
records.
c. The 12 lead must include;
i. The call run number
ii. Patient name
iii. Age
iv. Date of service
v. Receiving hospital
Documentation Guidelines
While our first and most important job is to provide patient care, all patient care and assessments must
be accurately recorded. This includes the patient s primary complaint; the patient’s presenting signs
and symptoms (assessment); and all treatments and interventions, both attempted and successful.
Deviations from protocol must also be documented, to include the reason the deviation occurred.
Protocol deviation narrative should also include the method used to notify supervising staff and/or the
medical director.
High-risk medicolegal situations require additional and thorough narrative, such as cases involving: an
unexpected death in the field or death of a young person; a prolonged resuscitation; a complex multi-
casualty incident with multiple patients and involvement of outside services; situations where law
enforcement personnel are also on scene due to violence or other civil disturbances; or cases when the
patient or family are visibly displeased with care provided. Additional details are useful to hospital-
based providers, are important during quality reviews, and may confer protection in the case of a
lawsuit.
All patient care reports (PCR’s) must be completed by the end of shift.
There are 5 main reasons to document EMS call Clinical, Legal, Operational, Financial, and Compliance.
1. Times and dates: Make sure that all times and dates are recorded and correct.
2. Addresses of scene and destination: should include city and county.
3. Patient’s complaint on arrival: What was the patient’s primary complaint? Use patients own
words to describe the complaint when possible. Patient describes pain as “Crushing sensation in
the center of chest”.
4. Patient assessment: A primary assessment, including vital signs, must be completed on every
patient contact. This includes transports and patient refusals. All refusals’ need to 2 sets of vital
signs.
5. Patient demographics: Accurately record patient’s name, mailing address, DOB, SSN, and
telephone number. If unable to ascertain the patient’s name, state is requiring that UNKNOWN,
UNKNOWN for both last and first name.
6. Patient history, medications, and allergies: Obtain a list of the patient’s past medical history, all
medications taken by patients and list any allergies.
7. Treatments: A complete listing of all interventions and medications including time given. How
did patient response to treatment? Be sure to include both successful and unsuccessful
attempts. Including movement of patient. ( draw sheet, S.L.I.P., or bariatric equipment used)
8. Billing information: Every attempt should be made to obtain the patients insurance
information. Ask for a face sheet at the ER or get a copy made of insurance card.
9. Mileage: Total loaded mileage must be documented on every transport.
10. Signatures: A signature is required for all patients. If patient is unable to sign, a family member
of care giver can sign for patient. If a family member or care giver is not available, you will need
to note why patient is unable to sign, for example “patient is unable to sign due to AMS”.
The following six sub-sections forward important data to GAAA QA and DSHS:
Non-Emergency Transfers
Spelling and grammar (i.e. capital letters, punctuations, and complete sentences) are extremely
important components of the patient care narrative, both for professionalism and medicolegal reasons.
Do not use unapproved abbreviations. Most abbreviations are upper and lower case sensitive. If you
are not sure whether an abbreviation is acceptable or not, write it out.
If you give treatment to a patient like a public assist, or bandage a wound you must fill out an ePCR.
All refusals must have 2 sets of vital signs, and document that you have explained the possible
consequences of the patient not seeking medical attention.
Leaving patients on-scene should not be a routine procedure. It is to be considered only when a
patient requires immediate transport in order to maximize potential outcome.
The transport provider may transfer patient care to a provider of a lower skill level while
awaiting additional transport resources when transfer of established care is not beyond the
scope and/or training of the provider.
When a patient presents without need for MICU level care and a BLS/ALS unit is available,
patient care may be transferred at the discretion of the on-duty shift supervisor.
Mass and multi-casualty incident transport decisions will be made by the transport officer.
Units may not respond non-emergency to a call for service for the sole reason that the caller
requests “No Lights and Sirens.”
Police, fire and other first responders can disregard responding units, but may not do so in order
to contact another transport provider.
Off-duty GAAA providers may downgrade or disregard responding units.
Dispatch may not disregard units when a caller requests EMS cancel their response; the
responding units must continue to the scene.
Mutual Aid:
When providers are requested to respond through an official channel for mutual aid; these
protocols remain in effect.
If a provider is dispatched on a radio channel separate from GAAA’s primary radio channel, the
responding unit must advise GAAA dispatch and the on-duty supervisor that they are responding
to a mutual aid request.
provided by dispatch and that the crew can make location prior to the arrival of the
vessel or aircraft.
o When directed to do so by the on duty supervisor.
On-Line Medical Consultation (OLMC): Providers have several options for OLMC:
Contact the receiving facility where the patient is being transported and speak with an ER
physician.
Contact the GAAA medical director, Dr. James Vincent.
At certain times it may be appropriate to contact the patient’s regular treating physician.
For inter-facility transports the provider should obtain written orders specific to the patient for
any treatments that are outside the provider’s standard scope of practice.
Nurses and other ancillary staff may not give providers treatment orders.
Once OLMC has been established the provider should follow the orders given by the physician that is
assuming care of the patient. However in cases that the provider feels the prescribed treatment would
violate accepted medical standards, supervisory guidance should be requested and the provider should
not follow those directives that may cause harm to the patient. In the event of a disaster situation or
other extreme circumstance, even if expressly directed by an OLMC physician, providers are prohibited
from performing field C-sections or field amputations.
Flight Operations: GAAA responds when dispatched to PHI out of Scholes field to provide medical care
to offshore locations such as ships and oil-rigs in the Gulf of Mexico. Providers may transport to a
variety of facilities along the US Gulf Coast.
For safety, GAAA providers are required to wear long pants and boots on all flights.
Additional equipment is located in the supply lockers at Scholes field in the PHI terminal.
Flight physiology will affect patient’s condition and require differing techniques to care for the
patient than ground based transport.
o Patients may require supplemental oxygen
o IV fluids will not flow in the absence of pressure infusers
o Entrapped air may expand in the patient’s body cavities.
OLMC is typically not available for providers responding off-shore; so Team Captains are
required on all flights.
If the shift supervisor is required to maintain system status by sending a non-team captain
paramedic on an offshore flight, that provider is permitted to utilize all treatment pathways,
including those at Team Captain level skills.
Overview: Air medical transport is an important adjunct to the overall care of the severely ill or injured
patient. Air medical provider (AMP) resources should be utilized in accordance with the regional trauma
plan.
Purpose: These AMP activation guidelines are intended to provide a framework for each RAC to develop
a standardized method for ground emergency medical service providers to request a scene response by
an AMP, to reduce delays in providing optimal care for severely ill or injured patients, and to decrease
mortality and morbidity.
Decision Criteria: AMP activation/scene response should be considered when it can reduce
transportation time for severely ill or injured patients meeting activation criteria. Should there be any
question whether or not to activate regional AMP resources, on-line or receiving facility medical control
should be consulted for a final decision.
1. The ground emergency medical service provider may, when one or more of the
elements of the activation criteria exist, request a scene response by an AMP and assist
with transportation to an appropriate acute care facility.
2. Ground emergency medical service providers should not remain on scene awaiting AMP
arrival if ground transport time will be less than the combined arrival and return time of
the AMP.
3. Ground emergency medical service providers should activate the AMP as early as
possible, including prior to their arrival at the scene if the mechanism of injury or scene
report meets criteria.
4. The EMS provider should comply with RAC-approved triage criteria (such as that listed
below) to activate AMP transport.
5. Other factors that should be considered are:
a) Location of incident
b) Number of patients
c) Age of patients
d) The total AMP response time (response time+ scene time +transport time) will
result in delivery of the patient(s) to the most appropriate facility faster than
transport by ground ambulance.
e) Weight of patients
f) AMP activation will provide access to advanced life support interventions critical for
patient survival that are not available on scene (and more quickly than ground EMS
can arrive at the nearest hospital).
g) Special circumstances & patient injuries (transport of suspected spinal injury over
rough terrain) where patient outcome would be improved by AMP transport.
6. In all instances the available AMP that best meets the needs of the patient will be
utilized.
Other considerations: Trauma patients meeting criteria for AMP dispatch should be transported to a
Level I, II, or III Trauma Center. Severely ill medical patients should be transported to the nearest
appropriate acute care facility.
1. Severely injured or ill patients located in a remote or off-road area not readily accessible
to ground ambulance.
2. Ground resources with acceptable response time exhausted or exceeded in the region.
3. Reduction in transport time to a trauma center compared to ground transport for the
seriously injured trauma patient.
4. Motor vehicle collisions involving:
a. Ejection
b. Rollover
c. Death in same patient compartment
d. Patient extrication of 20 minutes or greater
5. Falls from a distance of greater than 20 feet
6. Auto-pedestrian injury with significant impact (> 20 mph)
7. Physiologic:
a. Glasgow Coma Scale of less than 10
b. Systolic blood pressure of < 90 with signs/symptoms of shock
8. Anatomic:
a) All penetrating injuries to the head, neck, torso, and/or extremities proximal to the
elbow and knee
b) All penetrating injuries to the head, neck, torso, and/or extremities proximal to the
elbow and knee
c) Flail chest
d) Combination trauma with burns of 20% involving face or inhalation injuries
e) Major burns including:
i. Inhalation
ii. 2nd or 3rd degree burns > 20% BSA
iii. Combination trauma with burns
f) Two or more proximal long-bone fractures
g) Pelvic fractures
h) Traumatic paralysis
i) Amputation proximal to the wrist or elbow
j) Depressed or open skull fractures
9. Multiple severely injured patients on scene
10. No available trauma center within one hour of ground transportation.
Specialty Care:
T r a n s p o r t decisions for specialty problems such as Trauma, Stroke, ACS/STEMI, Pediatric Care
and Burns will be made with attention to local hospital and regional protocols. Evidence-based
support fueling national quality initiatives to bring a patient to a certified/accredited specialty
center will be weighed against the need to bring a critically unstable patient to the closest
available facility.
Local Stroke Resources: Patients presenting with acute stroke symptoms less than 6 hours
in onset will be preferentially taken to a stroke center when possible. Air medical
transport may be considered for select patients with symptom onset less than 2 hours in
order to facilitate time-dependent lytic therapy.
ACS/STEMI: Patients experiencing acute STEMI are best managed in facilities with active
cath lab programs and should be preferentially taken to these centers. The receiving
hospital emergency department physician should be notified while en route. The field EKG
demonstrating the STEMI should be transmitted electronically to the receiving hospital
when possible, in order to facilitate activation of the cath lab before arrival when
appropriate.
Pediatric Care: Children with critical illness or injury and children with chronic underlying
medical conditions should be preferentially transported to a facility capable of caring for
the child’s critical illness or special needs. The parents should be enlisted to assist with
destination decisions whenever possible.
Burn Care: Patients fulfilling criteria for major burns (see burn care protocol) should be
transported to a burn center whenever possible.
(Per the Texas State Board of Medical Examiners (TSBME), the licensing body for physicians in Texas.)
Control at the scene of a medical emergency shall be the responsibility of the individual in attendance
who is most appropriately trained and knowledgeable in providing prehospital emergency stabilization
and transport.
Types of Consent
Informed Consent: This is the legal standard regarding the process in which the patient refuses
or consents to medical care.
o The patient is competent and able to make a decision about their medical care.
o The patient is given all the necessary information a reasonable person would require to
make the decision including: risks, benefits and alternatives
o The patient is capable of deliberating and communicating their choice.
Implied Consent: This type of consent regards the legal standard for consent during a life-
threatening emergency. Patients must be:
o Unable to communicate because of an injury, accident, illness, or unconsciousness and
suffering from what reasonably appears to be a life-threatening injury or illness
o OR suffering from impaired present mental capacity
o OR a minor who is suffering from what appears to be a life-threatening injury or illness
and whose parents, guardians or managing or possessory conservator are not present.
o Patients who are not mentally competent or have an impaired present mental capacity.
The latter case will generally require law enforcement assistance.
Substituted Consent: When another person consents for the patient such as for minors,
incapacitated patients, incarcerated patients and those who have been deemed by a court of
law to be legally incompetent.
A minor is able to consent or refuse medical care in a limited set of circumstances in Texas.
Emancipation: This requires a court order in the state of Texas.
Minors who are on active military duty with the US Military
When consenting to the diagnosis and treatment of an infectious, contagious, or communicable
disease that is required by law or rule to be reported by the licensed physician or dentist to a
local health officer or the Texas Department of State Health Services
Is consenting to examination and treatment for drug or chemical addiction, drug or chemical
dependency, or any other condition directly related to drug or chemical use
A minor can consent to counseling for suicide prevention, chemical addiction or
dependency, or sexual, physical or emotional abuse
Minors who are married are considered emancipated
Pregnancy:
Minors may consent or refuse medical care related to the care of their unborn child or for their
pregnancy.
Minors may also consent or refuse medical care and treatment of their child if they have
custody of that child.
Who other than the parents of a minor can consent to or refuse medical treatment?
Per Texas Statutes- Family Code §32.001
Grandparent
Adult brother or sister
Adult aunt or uncle
Any educational institution in which the minor is enrolled and has written
authorization from persons having power to consent
Any adult who has actual care, control and possession of the minor and has written
authorization to consent for medical treatment.
A court having jurisdiction over a suit affecting the parent-child relationship of which the child is
the subject
A peace officer who has lawfully taken custody of minor, if the peace officer has reasonable
grounds to believe the minor is in need of immediate medical treatment.
A managing or possessory conservator or guardian.
A provider may be denied access to minor children by a parent or guardian if there is no obvious
immediate life threat to the patient. However, in general, parents or guardians cannot refuse
life-saving therapy for a child based on religious or other grounds.
If the provider feels that the child is in immediate danger of a life threatening illness or injury
and the parent or guardian is refusing medical care, contact law enforcement for assistance in
treatment and transport.
In the event of an unaccompanied minor that requests refusal of medical care, consent may be obtained
via telephone by contacting the parent or guardian of the minor.
Termination of CPR
Termination of CPR is a difficult decision for clinicians. Termination of CPR should not be performed in
public locations with the exceptions of hospitals, nursing home, assisted living facilities and other
healthcare facilities. Termination may be performed in private residences and where the deceased and
family’s privacy can be respected. Termination efforts involve the entire family if present and after a
field termination care and guidance should be redirected to the family and friends present at the
resuscitation.
Resuscitation should not be initiated when any of the following is noted:
Any provider, in the following circumstances, may discontinue resuscitation efforts without OLMC:
Resuscitation efforts were inappropriately initiated when criteria to not resuscitate were present.
A valid OOH-DNR or advanced directive was discovered after resuscitative efforts were initiated.
As per the limited termination of resuscitation(TOR) protocol (see below)
For traumatic arrest only: when an EKG is applied after resuscitation is initiated and a PEA <40 or
asytole is noted. (Paramedic)
Termination of appropriate Resuscitation Efforts Utilizing OLMC: There are instances when a provider
must contact OLMC when considering discontinuation of resuscitation efforts. These include but are not
limited to the following circumstances:
Patients have a legal right to consent to, or refuse, recommended medical procedures, including
resuscitative efforts. The decision to honor, or not to honor, an OOH DNR must be made quickly and
accurately. Remember, it is our obligation to carry out the patient’s appropriately designated medical
choices.
An OOH DNR order should NOT be honored and resuscitative efforts should be initiated in the
following circumstances:
o The patient or person who executed the order destroys the form and/or removes the
identification device.
o The patient or person who executed the order directs someone in their presence to
destroy the form and/or removes the identification device.
o The patient or person who executed the order tells the EMS providers or attending
physician that it is his/her intent to revoke the order.
o The attending physician or physician’s designee, if present at the time of revocation, has
recorded in the patient’s medical record the time, date, and place of the revocation and
enters “VOID” on each page of the DNR order.
o The patient is known to be pregnant.
o In the event that there is a question as whether to honor or not honor an OOH DNR or
Advanced Directive, contact OLMC as needed.
Important Points to Remember
o Always rule out a non-traumatic etiology for what may be perceived as a traumatic
arrest (for example, primary ventricular fibrillation resulting in a minor car crash).
o Anytime a DNR is not honored, the reason must be documented in the patient care
record (PCR).
o An advanced directive does not imply that a patient refuses palliative and/or supportive
care. Care intended for the comfort of the patient should not be withheld based on a
medical power of attorney.
When an EMS provider honors an appropriately executed DNR order, the law provides
protection against any charges of aiding in suicide 9Section 22.08 of the Penal Code -TAC
166.047.
When in doubt, always initiate resuscitative efforts. Later termination can be implemented if
appropriate.
Hospice Patients
When a patient with a severe illness decides that curative measures are no longer appropriate or
effective, the option of hospice care is a compassionate, dignified and cost-effective end-of-life care
option. The address where a hospice patient resides will ideally be flagged from dispatch to allow for
appropriate identification of these patients. While a patient or legal surrogate may reverse a hospice
decision at any time, transport of these patients inappropriately to the hospital emergency room
generally will trigger loss of funding for the patient.
As end-of-life issues are difficult for patients and healthcare professionals alike, the shift Supervisor or
Medical Director should be contacted immediately for assistance should any questions or concerns arise
during the care of these patients.
Scope of Practice
The State of Texas does not have a state-mandated scope of practice. Each system determines the
providers’ scope of practice.
Inter-facility Transfers:
When transferring a patient who requires transport to a higher level of care or for specialty services not
available at the sending facility the following guidelines should be used:
Consult with the on-duty shift supervisor for any patient care issues that cannot be resolved through this
document. If called to transport a patient that is potentially unstable for transport, assess and consult
with the treating physician.
Consistent with the intent of EMTALA, the transfer of a patient not stabilized for transport may be
preferable to keeping that patient at a facility incapable of providing stabilizing care. If the patient
requires advanced treatment or interventions that are beyond the scope of prehospital providers the
facility should provide appropriately trained staff to accompany the patient.
Additional staffing:
If the staff member is an RN, he or she will maintain patient care responsibility and function
within his or her scope of practice and under the orders of the transferring physician. The GAAA
provider(s) and the RN will work together to provide patient care. If the patient deteriorates en
route the Paramedic will assume care outside the RN’s scope of practice.
If the additional staff member is an RT, he or she will manage ventilator settings and all
treatment under his or her scope of practice. The paramedic will assist as needed and manage
the comprehensive patient care.
If the additional staff member is a physician, then that physician will remain in charge of patient
care. The GAAA provider will assist as required.
If the additional staff member is a flight paramedic, GAAA providers will assist as required and,
unless requested, the patient will remain in the care of the flight paramedic.
Due to the unique nature of inter-facility transports, providers will encounter medications and invasive
procedures that are not typically utilized in pre-hospital treatment. Providers should not monitor
medications or devices that they are not familiar with. Providers should not take possession of any
medication that is not from GAAA formulary to administer to the patient en route. Providers may
monitor and transport an extended formulary but should not institute or titrate any medications or
infusions not stated in this document. Limited titration can be performed by paramedics with written
orders.
Dial-a-flows are not appropriate for medication and infusion monitoring on inter-facility transfers.
EMT- Basics are permitted to transport and monitor all patients as noted in GAAA protocols and:
Monitor only:
Established (greater than 2 week placement) of tracheostomy patients on home ventilators with
pre-set ventilator settings.
NG/OG tubes.
Internal pacemakers.
Spinal stimulators.
Foley catheters.
Central venous access lines without infusions excepting patient controlled devices.
Peripheral lines containing plain isotonic or glucose solutions without medications added. May
adjust per the patient’s condition and/or written orders from the sending facility.
IV antibiotics running at a KVO rate or on an infusion pump if the medication has been initiated
by the sending facility.
Ventilator patients that do not require sedation, paralysis, EKG monitoring or other advanced
procedure.
Non-Team captain Paramedics will require written orders to administer sedation or paralysis
for intubated patients on ventilators.
Administer but not initiate glucose or isotonic IV fluids that are not standard GAAA formulary.
May monitor and adjust IV solutions containing potassium less than 20mEq/L.
Medications that GAAA providers may monitor without titration and administered through an
infusion pump. In the event of an infusion pump malfunction, the infusion should be stopped
and the appropriate facility contacted for guidance.
Heparin Magnesium
Antibiotics Mannitol
The following medications may be titrated with written orders from the sending facility :
IV Nitrates Anti-dysrhythmics
Lidocaine
NOTE: Although the sending facility may have initiated medication(s), Paramedics MUST be familiar with
the medications that the patient may be receiving at the time of transfer. Reminder: interfacility
medications are not to be initiated by Paramedics.
Ventilators
PIC Lines
Bladder Irrigation
Chest tubes
Femoral lines
Paramedics may transport patients with femoral sheaths that are not currently accessed. Patients that
have arterial line monitoring, active ICP monitoring devices or Intra-aortic balloon pumps require
additional trained personnel from the sending facility to monitor and manage those devices.
In the setting of national medication shortages, when it is deemed to be in the patient’s best interest to
use an expired medication, as opposed to either an inferior alternative or no medication, an expired
medication may be used. Additionally, providers will not be responsible for giving medications in any
protocol in which the medicine is unavailable due to national shortages or supply issues. Clinically
appropriate pharmacologic substitutions may be authorized on a case-by-case basis and communicated
directly to field staff by the medical director.
Does the
patient have a Proceed with normal
NO
fever > 38*C or call process
100.4*F
YES
Topic: 4.02 – Guidance for Emergency Medical Services (EMS) Systems for 9- 10.21.14
1-1 Public safety Answering Points (PSAPs) for Management of Patients with
Known or suspected Ebola Virus Disease (EVD) 2014 - Author
Audience Healthcare personnel in the UTMB Emergency Department (ED) and personnel in the
EMS.
I. Transport of patients with possible EVD based on 9-1-1 calls to the EMS
A. When calls come in to the dispatcher requesting Transport of a patient with possible
EVD, the dispatcher should ask the following questions:
1. Do they or someone else with them have a fever of greater than 38*C or
101.5*F and if they have additional symptoms such as severe headache,
muscle pain, vomiting diarrhea, abdominal pain or unexplained bleeding?
2. If the patient has symptoms of Ebola, then ask the patient about risk factors
within the past 3 weeks before the onset of symptoms, including:
a. Has the patient had contact with blood or body fluids of a patient
known to have or suspected to have EVD?
b. Has the patient had residence in-or traveled to a country where an
Ebola outbreak is occurring?
a. Guinea
b. Sierra Leone
c. Liberia
d. Nigeria
c. Has the patient handled bats or non-humans primates from the
disease-endemic areas?
d. If the dispatcher has information from the above queries suggesting
that the person may possibly have EVD, they should make sure that
the EMS personnel are made confidentially aware of the potential
for EVD so that responders can don appropriate PPE before they
arrive at the scene.
II. Transport of cases of possible EVD from UTMB outlying Clinics to the UTMB ED
A. Cases that present to UTMB Clinics with possible EVD will be screened using the
same screening protocol as that used by the UTMB ED.
In the setting of national medication shortages, when it is deemed to be in the patient’s best interest to
use an expired medication, as opposed to either an inferior alternative or no medication, an expired
medication may be used. Additionally, providers will not be responsible for giving medications in any
protocol in which the medicine is unavailable due to national shortages or supply issues. Clinically
appropriate pharmacologic substitutions may be authorized on a case-by-case basis and communicated
directly to field staff by the medical director.
Does the
patient have a Proceed with normal
NO
fever > 38*C or call process
100.4*F
YES
Topic: 4.02 – Guidance for Emergency Medical Services (EMS) Systems for 9- 10.21.14
1-1 Public safety Answering Points (PSAPs) for Management of Patients with
Known or suspected Ebola Virus Disease (EVD) 2014 - Author
Audience Healthcare personnel in the UTMB Emergency Department (ED) and personnel in the
EMS.
I. Transport of patients with possible EVD based on 9-1-1 calls to the EMS
A. When calls come in to the dispatcher requesting Transport of a patient with possible
EVD, the dispatcher should ask the following questions:
1. Do they or someone else with them have a fever of greater than 38*C or
101.5*F and if they have additional symptoms such as severe headache,
muscle pain, vomiting diarrhea, abdominal pain or unexplained bleeding?
2. If the patient has symptoms of Ebola, then ask the patient about risk factors
within the past 3 weeks before the onset of symptoms, including:
a. Has the patient had contact with blood or body fluids of a patient
known to have or suspected to have EVD?
b. Has the patient had residence in-or traveled to a country where an
Ebola outbreak is occurring?
a. Guinea
b. Sierra Leone
c. Liberia
d. Nigeria
c. Has the patient handled bats or non-humans primates from the
disease-endemic areas?
d. If the dispatcher has information from the above queries suggesting
that the person may possibly have EVD, they should make sure that
the EMS personnel are made confidentially aware of the potential
for EVD so that responders can don appropriate PPE before they
arrive at the scene.
II. Transport of cases of possible EVD from UTMB outlying Clinics to the UTMB ED
A. Cases that present to UTMB Clinics with possible EVD will be screened using the
same screening protocol as that used by the UTMB ED.
Scene Safety
EXPECATIONS FOR EVERY
PATIENT ENCOUNTER:
- GCHD Badge displayed Bring all necessary
- Appropriate dress code equipment to the patient
- Highest degree of
professionalism PPE As Needed
Initial Assessment
PREOXYGENATE PT 100% O2
PEDI DOSAGES VIA BVM FOR 30-90 SEC INDICATORS OF SUCCESSFUL
Etomidate INTUBATION
0.3 mg/kg
ETOMIDATE 20MG Visualization of tube going
Succinylcholine AND/OR through cords
1 mg/kg VERSED 5MG
Audible and equal breath sounds
Rocuronium
Lack of sounds over epigastrium
1mg/kg
SUCCINYLCHOLINE POSITIVE END-TIDAL CO2
Versed 100 MG IV Improvement in vital signs and
0.1 mg/kg color.
Vecuronium ASSESS ALL OF THE ABOVE AFTER
INTUBATE PT EACH ATTEMPT
0.1 mg/kg
(CONSIDER KING VISION
WHEN AVAILABLE)
YES NO
SUCCESSFUL
INTUBATE PT WITH
FENTANYL
PROPER SIZE ET TUBE YES
100 mcg IV
FAILED AIRWAY
Indications:
SpO2 <90%
NO YES
NO YES
SpO2 drops below <90% or
becomes difficult to ventilate
with BVM Announce over the Radio “Medic
______ Failed Air-way Protocol”
Ventilate PT at a ≤ 12 / min,
keeping SpO2 above 90%
SpO2 <90% YES
Continuous pulse oximetry when available and ETCO2 monitoring should be used in all
patients with inadequate respiratory function.
JamesVincent
NotifyM.D.
receiving Emergency Department ASAP about patients with failed air-way. Page 42
Medical Protocols
PAIN MANAGEMENT
Clinical Indications:
Patients that need pain management and are unable to obtain adequate relief with non-
pharmaceutical measures
General Pain
Management
AND / OR
Morphine 2-5mg IV
May repeat X1
POLICE CUSTODY
History: Signs and Symptoms: Differential:
Appropriate
Suspected Traumatic Injury or
Protocol
medical condition.
Pepper Spray
Minor Laceration Taser
or Abrasions?
Irrigate Eyes and Face
w/ water. Remove Appropriate wound
Taser Barb
contaminated clothing care.
Removal Protocol
Wheezing NO
Coordinate disposition with LEO
and if necessary medical control
YES COPD/Asthma
and the on-duty Supervisor.
Protocol & Transport
ALLERGIC REACTION
Signs and Symptoms: Differential:
Stable Unstable
Epinephrine 1:1000
0.3mg IM
May repeat X1 in 5 min
Benadryl 25-50 mg
SIVP or IM NS Bolus 1000 cc IV
The shorter the time from the patients exposure to the onset of symptoms, the more severe
the reaction.
Apply cold packs. May be applied to bites and stings in order to reduce the swelling and slow
blood flow from the affected are.
Famotidine is an antacid with H2 antagonist properties that has been shown to work well for
James Vincent
hives M.D.
and other allergic reactions. Page 45
Medical Protocols
ANXIETY
History: Signs and Symptoms: Differential:
Verbal Calming
Versed 1-2mg
IN/IM/IV may repeat
once
This Protocol is NOT to be implemented for patients who are refusing EMS care and are
legally mentally competent and able to refuse care.
The majority of patients that present with uncomplicated anxiety will not require
Jamespharmacological
Vincent M.D. management. Verbal calming and empathy is generally effective. Page 46
Consider midazolam 0.5 mg IV for elderly patients.
Medical Protocols
BEHAVIORAL EMERGENCY
History: Signs and Symptoms: Differential Diagnosis:
Suspected Stimulant Overdose should be treated with Valium / Versed until pt is calmed or
systolic blood pressure of 100 is reached.
Do not restrain in the prone position. Physical restraints without chemical restraint can
increase the risk of Excited Delirium in susceptible patients.
For agitated or very combative patients do not restrain without adequate sedation to reduce
the risk of excited delirium.
Patients restrained using handcuffs in police custody must be transported with law
enforcement’s assistance.
This Protocol is NOT to be implemented for patients who are refusing EMS care and are
legally able to do so.
If the patient is suspected of excited delirium and cardiac arrest ensues, Sodium Bicarbonate
James Vincent M.D. Page 47
and fluid bolus should be administered early in the arrest. If available cooled IV fluids should
be used. Consider passive cooling.
After restraint procedures are used the patient will require continuous monitoring.
Medical Protocols
EXCITED DELIRIUM
History: Signs and Symptoms: Differential Diagnosis:
Versed
CARDIAC ARREST 5 mg IV/IM/IN
If Geodon is given IV, immediacy contact the medical director and notify the Clinical
Coordinator ASAP.
Do not restrain in the prone position. Physical restraints without chemical restraint can
increase the effects of Excited Delirium and are inhumane.
Patients restrained using handcuffs in police custody must be transported with law
enforcement’s assistance.
This Protocol is NOT to be implemented for patients who are refusing EMS care and are
legally able to do so.
If the patient is suspected of excited delirium and cardiac arrest ensues Sodium Bicarbonate
James Vincent M.D. Page 48
and fluid bolus should be administered early in the arrest. If available cooled IV fluids should
be used. Consider passive cooling.
Medical Protocols
COPD / ASTHMA
Signs and symptoms: Differential:
Solumedrol 125mg IV
Consider C-PAP
Apply ETCO2 Device
5cm H20
DIABETIC EMERGENCIES
History: Signs and Symptoms: Differential Diagnosis:
Dextrose 50%
25 grams IV / IO Treat associated
symptoms
Thiamine 100 mg
IV/IM for chronically
malnourished pts.
Pt refusals: If a hypoglycemic pt wishes to refuse transport after treatment, and the provider has no
concerns about underlying medical conditions, or the ability of the person or care giver to manage
their disease ensure the following conditions are met:
HYPOTENSION
Signs and Symptoms: Differential Diagnosis:
SYSTOLIC BP < 90 WITH SYMPTOMS Shock- Carcinogenic, Septic, Neurogenic,
Lightheaded, Dizziness Anaphylactic
Positive Tilt test Pregnancy
Altered Mental Status Ectopic Pregnancy
Restlessness, Confusion Dysrhythmias
Weak, rapid pulse Pulmonary Embolus
Pale, cool, clammy skin Tension Pneumothorax
Coffee ground emesis, Tarry Stool Medication Effect / Overdose
Vasovagal
NS Bolus 500cc,
Repeat until
30mL/kg given
Go to
Epinephrine 10 mcg = 1mL appropriate
Q 2-5 minutes protocol once
Norepinephrine OR 5-20 mcg/min IV infusion etiology
determined
2-12 mcg/min IV Titrate to SBP >90
Target MAP 65
NAUSEA / VOMITING
Signs and Symptoms: Differential:
Nausea Infection (viral, food-borne)
Vomiting Toxin, overdose, drugs, alcohol
Dry lips, sunken eyes Increased intracranial pressure (stroke,
Tachycardia, hypotension hemorrhage, trauma)
Acute coronary syndrome
>4 yo:
Zofran 4 mg IV or IM
Activated Charcoal
OVERDOSE
Signs and Symptoms: Differential:
Irregular or rapid respirations. Head trauma
Shallow respirations or apnea. Hypoglycemia
Bradycardia Hyperglycemia
Tachycardia Hypoxia
Altered mental status.
RESPIRATORY DISTRESS
Sign and Symptoms Differential Diagnosis
Apply Oxygen
SEIZURE
History: Signs and Symptoms: Differential:
Seizure Reoccurs
OR
Airway Positioning,
Valium 10mg IV RSI Protocol
Nasopharyngeal airway, O2,
BVM Ventilations as needed
STROKE / CVA
Sign and Symptoms Differential
12-lead ECG
SYNCOPE
History: Signs and Symptoms: Differential:
Cardiac history, Loss of consciousness Orthostatic
Stroke, Seizure with recovery Hypotension
Occult blood loss (GI, Lightheadedness, Psychiatric
Ectopic) dizziness Stroke
Fluid Loss: Nausea Palpations, slow or rapid Hypoglycemia
Vomiting, Diarrhea pulse Seizure
Past medical history. Pulse irregularity Shock
Medications Hypotension Heat exhaustion
Cardiac dysrhythmia
NS 500 to 1000 cc
Blood Glucose
SUPRA-VENTRICULAR TACHYCARDIA
Signs and Symptoms: Differential Diagnosis:
12 Lead EKG
YES STABLE NO
Synchronized cardioversion
Diltiazem 10-20 mg 150 joules
Repeat 25mg X1 in
10 min.
Amiodarone 150 mg
over 10 min
Unstable is defined by severe hypotension, altered mental status and/or weak or absent
radial pulses.
Sedation should not be used with hemodynamically unstable pts.
SVT refractory to Adenosine can be treated with Diltiazem if not contra-indicated.
Vagal maneuvers are contraindicated if pt has a HX of CVA, carotid surgery or carotid bruits.
CONTINUOUS PRINT-OUT OF MONITOR TRACING DURING CONVERSION IS VERY HELPFUL
FOR RECEIVING HOSPITAL’S CARDIOLOGIST.
A-FIB W/ RVR
Signs and Symptoms: Differential Diagnosis:
12 Lead EKG
YES STABLE NO
Synchronized cardioversion
Diltiazem 10-20 mg
100 joules
slow IV push
Synchronized cardioversion
150 joules
Unstable patients are ones with: severe hypotension, altered mental status and weak or
absent radial pulse.
Diltiazem requires a systolic blood pressure of at least 80-90 mm/Hg.
Sedation should be used with extreme caution on hemodynamically unstable patients.
Consider using the minimum dose.
12 Lead EKG
Cardiac
Arrest No Wide, regular rhythm with Narrow
Protocol Pulse SVT
QRS >0.12 sec? Complex
Protocol
STABLE UNSTABLE
YES
Synchronized Cardioversion
150 joules
May repeat as needed
Amiodarone 150mg
over 10 min
may repeat x1
For witnessed / monitored ventricular tachycardia try having the patient cough.
Polymorphic V-Tach (Torsade’s de Pointes) consider Magnesium Sulfate 2grams IVP
Notify receiving Emergency Department as soon as possible of the patient’s condition.
Brief episodes of ventricular ectopy do not require treatment (Formerly “Ventricular Ectopy”
protocol, which has been removed.)
SYMPTOMATIC BRADYCARDIA
Signs and Symptoms Differential Diagnosis
12 Lead EKG
ATROPINE 0.5MG-1MG
MAY REPEAT q 3-5 MIN
MAX DOSE 3mg
USE CAUTION: Atropine should be omitted for second degree Type ll or Third Degree AV
Heart blocks
DO NOT TREAT BRADYCARDIA IF PT HAS NORMAL BLOOD PRESSURE AND NO SYMPTOMS.
EMT-I may
establish IO when
indicated
12 Lead EKG
Cardiac
Arrest No Wide, regular rhythm with Narrow
Protocol Pulse SVT
QRS >0.12 sec? Complex
Protocol
STABLE UNSTABLE
YES
Synchronized Cardioversion
150 joules
May repeat as needed
Amiodarone 150mg
over 10 min
may repeat x1
For witnessed / monitored ventricular tachycardia try having the patient cough.
Polymorphic V-Tach (Torsade’s de Pointes) consider Magnesium Sulfate 2grams IVP
Notify receiving Emergency Department as soon as possible of the patient’s condition.
Brief episodes of ventricular ectopy do not require treatment (Formerly “Ventricular Ectopy”
protocol, which has been removed.)
Criteria Differential:
>34c and
<33C Reassess Temperature Shivering
If no advanced airway can be obtained, cooling may only be initiated with online medical
direction.
Do not delay transport to initiate cooling patient.
Patients may develop metabolic alkalosis with cooling. Do not hyperventilate.
Take care to protect patient’s modesty. Undergarments may remain in place during cooling.
HYPERTENSION
History: Signs and Symptoms: Differential Diagnosis:
12 Lead EKG
Nitroglycerin 0.4 mg
spray
Enalapril 1.25 mg Labetalol 10-20mg
may be repeated X2
Slow IV push Slow IV push
May repeat X1 Repeat q10 min X2
Asymptomatic hypertension does not require treatment regardless of how high the blood
pressure is. Treatment may interfere with compensatory mechanisms and cause harm.
Target Systolic blood pressure should be two thirds of the initial blood pressure.
Do not use labetalol if HR < 60
Labetalol onset 5-10 min with a peak effect of 30 min.
Never treat Blood pressure based on one set of vitals.
Avoid Nitroglycerin in pt who has taken erectile dysfunction drugs in the past 48 hrs
Consider C-PAP
RSI Protocol
Systolic Blood
Pressure > 140
Expect Hypotension
Nitro spray q3 min Give 250mL Bolus
1 Nitro Spray q 3 min X 5
for SBP >140 and refer to
Hypotension
Protocol
If systolic BP >140
ACS Protocol as
Enalapril 1.25 mg slow IV push
needed
May repeat X1
DO NOT administer Nitroglycerin to any patient who has used erectile dysfunction medications (Viagra, Cialas,
Levitra, etc.) in the past 48 hours due to possible severe hypotension.
If patient has taken nitroglycerin without relief, consider potency of the medication.
Nitroglycerin can be administered to a patient by EMS if the patient has already taken 3 of their own prior to
your arrival. Document it if the patient had any changes in their symptoms or a headache after taking their
own. Document the expiration date of the patients prescribed nitroglycerin.
Diabetics and geriatric patients often have atypical pain, or only generalized complaints.
Careful monitoring of LOC, BP, and respiratory status with above interventions is essential.
Acute pulmonary edema may be a sign of acute cardiac ischemia, which may give rise to cardiovascular
collapse and hypotension as well as malignant atrial and ventricular arrhythmias.
DO NOT withhold oxygen from hypoxic patients.
Taser barb removal Taser barb rem Taser barb removal oval
SELECTIVE SPINAL IMMOBILIZATION
VENTRICULAR ECTOPY
History: Signs and Symptoms:
Mechanism of injury Focal neurological deficit
Fall height Any spinal tenderness.
Drugs or alcohol use
Auto Pedestrian / Bicycle Accident
Diving incidents
Focal Deficit?
Distracting injury?
The patient must be able to
look up, touch chin to the
Spinal Exam: any point chest and from side, to side
tenderness to spine or with without spinal process pain.
range of motion?
Dangerous mechanism?
Ex: Fall > 3feet, mod to high speed MVA,
diving accident, ATV crash, auto-ped?
The decision not to immobilize must be fully documented and include all of the above
historical and exam findings.
Palpate each spinous process to assess for tenderness. Only if no tenderness was elicited,
perform a range of motion exam.
Partial Immobilizations:
o At times securing a patient to a rigid spine board may worsen a spinal injury if
present or may otherwise harm the patient. These patients may be transported in
semi-recumbent position with a c-collar.
o Examples of patients who may not tolerate supine positioning: agitated patients and
patients with decompensated CHF or with kyphosis.
James Vincent M.D. Page 69
Medical Protocols
1-2 L NS
MAJOR TRAUMA
SIGNS AND SYMPTOMS: DIFFERENTIAL:
CONTROL ALL
Consider Needle Consider Pain
MAJOR ASSESS FOR
Decompression Management Protocol
BLEEDING FOCAL NEURO
DEFICITS
EXTREMITY TRAUMA
Signs and Symptoms: Differential Diagnosis:
Pain
Swelling
Deformity
Altered Sensation / Motor function
Diminished Pulse / Capillary refill
Decreased extremity temperature
1-2g IV
1 Consider Tourniquet
Protocol
For patients with an amputation, time is critical. Transport and notify receiving hospital
immediately. (See Extremity Amputation Protocol)
Hip, knee and elbow fracture/dislocations have a high incidence of vascular compromise.
Urgently transport any injury with vascular compromise.
Lacerations must be evaluated for repair within 4 hours from the time of injury.
Consider Tourniquet
Amputation:
o All retrievable tissue should be transported. (DO NOT DELAY TRANSPORT for tissue retrieval)
o Rinse amputation with normal saline or sterile water.
o Wrap amputation in sterile gauze that has been moistened with normal saline or sterile water.
o Place in plastic bag or container; place container in separate container filled with ice. (if available)
o DO NOT PLACE AMPUTATED PART IN DIRECT CONTACT WITH ICE.
Continuously flush
Eye the affected area
Involvement for 10-15 min.
Chemical: ELECTRICAL:
Flush the affected area as soon as possible Do not contact the patient until you are sure
with the cleanest and most readily available the electricity source is disconnected.
saline or tap water using copious amounts of Attempt to locate contact points, both will
fluid. generally be full thickness burns.
Utilize industrial decontamination Anticipate Ventricular, or Atrial irregularity,
equipment/showers and MSDS information V-Tach, V-Fib, Heart Blocks and other
when available. dysrhythmias.
BURNS - THERMAL
Signs and Symptoms: Differential:
Burns, pain, swelling Superficial (1st Degree) Painful and Red
Dizziness or Loss of consciousness Partial Thickness (2nd Degree) Blistering
Hypotension Full Thickness (3rd Degree) Painless,
Airway Compromise charred or leathery skin.
Respiratory Distress / Wheezing Thermal
Hypotension / Shock Chemical
Signed Facial Hair or Nostril Hair Electrical
Assess Airway
Critical Minor
NOTE: Vinegar
irrigation of jellyfish
wounds is no longer
JELLYFISH recommended, STINGRAY
(except in cases of
Pacific box jellyfish
or Atlantic
Irrigate with copious Portuguese man-of- If able immerse the
amounts of saline over war stings, which are affected site in very hot
the wound. not endemic to water or place hot packs
Galveston.)
to the affected area.
Transport patients with severe systemic response or allergic reaction to jellyfish stings.
Jellyfish stings in the Galveston area are rarely serious despite the amount of pain. Rarely
toxic varieties can drift into the area and the patient will present in imminent collapse.
Stingray envenomation require medical attention due to the high risk of infection and risk of
retained barbs or foreign mater in the wound.
Transport and treat patients with high BSA % of jellyfish stings or patients with stings to the
mucosa due to the risk for infection, severe pain and cosmetic damage.
SNAKE BITE
History: Signs and Symptoms: Differential:
DROWNING / NEAR-DROWNING
History: Signs and Symptoms: Differential:
Submersions in water Unresponsive Trauma
regardless of depth Mental status changes Pre-existing medical
Possible trauma to Decreased or absent problems
c-spine vital signs Pressure injury
Temperature of water, Vomiting (diving)
possibility of Coughing Post-immersion
hypothermia Apnea syndrome
Stridor, Wheezing, Rales
Immobilize C-spine
Have a high index of suspicion for possible spinal injuries. Factors to consider are potential
underwater hazards, height of fall, neurological deficits or length of time missing.
With cold water drowning – resuscitate all. These patients have an increased chance of survival.
Some patients may develop delayed respiratory distress due to lung damage and capillary leak.
All victims should be transported for evaluation due to potential for worsening over the next
several hours.
Allow appropriately trained and certified rescuers to remove victims from areas of danger.
With pressure injuries (decompression / barotraumas), consider transport to a hyperbaric
chamber.
For SCUBA injuries contact Diver Alert Network 1-919-684-9111.
ACTIVE LABOR
Signs and Symptoms Differential Diagnosis:
NO
Child Birth
Procedure
Transport Rapid Transport
OB EMERGENCIES
All of the following are considered priority symptoms and should be
transport to UTMB or CLRMC due to possible need for emergency surgery.
Eclampsia
Universal Treatment Guidelines
Magnesium Sulfate 50% 2 gm
in 50 mL NS IV saline wide
open max 4 grams
Eclampsia is described as
seizures in a pregnant woman
that are not related to a
Diazepam 5 mg IV for active
preexisting brain condition.
seizures refractory to
magnesium sulfate
Ectopic Pregnancy
Should be considered as a Normal Saline 500-1000cc NS Bolus
possibility for patients with severe Consider Pain Management Protocol
abdominal/pelvic pain with known
pregnancy
Abrupto Placenta
Should be considered for pregnant High flow O2, position on left side
patients complaining of severe w/ padding;
“ripping” pain with possible NS Bolus 500-1000cc to maintain
hypotension. SBP >100
OB EMERGENCIES
Placenta Previa
Should be considered when Treatment for Hypotension: high-flow O2;
the placenta delivers prior Normal Saline 500-1000cc bolus to maintain
to the fetus. systolic BP >100; Position Patient on her left
side with padding under the abdomen.
Shoulder Dystocia
NEONATAL RESUSCITATION
Universal Treatment Guidelines
Delivery of Newborn
Routine Care
Term gestation?
Provide warmth
Breathing or crying? YES
Clear airway if needed
Good muscle tone?
Dry
Good color?
Ongoing evaluation
NO
Provide warmth
Position and clear the
airway
Dry, stimulate, reposition
Evaluate HR, Respiration,
Color
Persistent
Cyanosis 10-15 rapid
ventilations with Prepare for RSI
BVM will often Protocol if
Ventilate with PPV
stimulate apnea/cyanosis
spontaneous persist
HR<60
breathing
Chest Compressions
Pediatric Cardiac
Arrest Protocol &
Transport
Insert IO
EMT-I Consider
may use advanced
Epinephr airway
ine
ET Tube size
Uncuffed Cuffed
0-1yr 3.5 3.0
1-2yr 4.0 3.5
>2yr 4+(age/4) 3.5+age/4)
D10 D25
5 ml/kg 2 ml/kg
Patients that need pain management and are unable to obtain adequate relief with non-
pharmaceutical measures
General Pain
Management
Fentanyl 1 mcg/kg
IV/IN/IM
May repeat X1
OR
For sickle cell Patients also consider 5cc/kg bolus of Normal saline.
For hemodynamically unstable patients Fentanyl should be first line treatment.
Morphine should be administered only with systolic pressure >90 and pt is not presenting
with signs of imminent circulatory collapse.
Consider administration of Zofran early when administering Morphine.
Our goal is not complete cessation of pain, aim for 50% reduction of pain.
Monitor for respiratory depression.
Stable Unstable
NS Bolus 20cc/kg
Max 1000cc Epinepherine 1:1000
0.01 mg/kg IM
Max dose 0.3mg
Solumedrol 2mg/kg IV/IM may repeat 1 in 5 min
Max dose 125mg
The shorter the time from the patients exposure to the onset of symptoms, the more severe
the reaction.
Apply Cold Packs may be applied to bites and stings, in order to reduce the swelling and slow
blood flow from the affected are.
Famotidine is an antacid with H2 antagonist properties that has been shown to work well for
hives and other allergic reactions.
PEDIATRIC SEIZURE
History: Signs and Symptoms: Differential:
Versed 0.1mg/kg
IN/ IV/IM/buccal Seizure Reoccurs Diabetic Protocol
Max dose 5 mg
May repeat X1
in 5 min
Airway Positioning,
Nasopharyngeal airway, O2, Consider RSI Protocol
OR
BVM Ventilations as needed
Valium 0.2mg/kg
IV Max dose 10mg
ASTHMA
Asthma History, BRONCHIOLITIS CROUP
Normally > 1 yo Infant < 1yo Toddler
Wheezing on exam Wheezing, tight Barky cough,
cough, thick nasal stridor
secretions
Albuterol 2.5mg /
Atrovent 0.5 mg
may repeat x3
A careful lung exam will reveal source of respiratory distress and can guide treatment decisions.
Epinephrine IM is appropriate for use when respiratory failure is imminent, which in children is
signified by a sudden SLOWING in respirations and markedly DEPRESSED MENTAL STATE, (both
indicators of carbon dioxide build-up).
James Vincent M.D. Page 88
Medical Protocols
NEONATAL RESUSCITATION
Universal Treatment Guidelines
Delivery of Newborn
Routine Care
Term gestation?
Provide warmth
Breathing or crying? YES
Clear airway if needed
Good muscle tone?
Dry
Good color?
Ongoing evaluation
NO
Provide warmth
Position and clear the
airway
Dry, stimulate, reposition
Evaluate HR, Respiration,
Color
Persistent
Cyanosis 10-15 rapid
ventilations with Prepare for RSI
BVM will often Protocol if
Ventilate with PPV
stimulate apnea/cyanosis
spontaneous persist
HR<60
breathing
Chest Compressions
Pediatric Cardiac
Arrest Protocol &
Transport
Insert IO
EMT-I Consider
may use advanced
Epinephr airway
ine
ET Tube size
Uncuffed Cuffed
0-1yr 3.5 3.0
1-2yr 4.0 3.5
>2yr 4+(age/4) 3.5+age/4)
CAPNOGRAPHY (ETCO2)
Indications:
TECHNIQUE
1. Visualize the ET tube passing through cords with King Vision (when available)
2. Assess for breath sounds high in the axilla, on the anterior chest, and over the
epigastrium
3. Apply the ETCO2 monitor. REQUIRED WITH ALL INTUBATED PATIENTS
4. Note the following ETCO2 information on the ePCR:
a. The initial ETCO2 value and presence or absence of a good waveform
b. A repeat ETCO2 value one minute or so later and quality of waveform
c. Successful intubation is indicated by:
i. ETCO2 of 5 or greater
ii. Good waveform
5. Continuously monitor waveform and ETCO2 value during transport as a sign of tube
dislodgement or loss of pulse.
For all patients, consider the following when ETCO2 is outside the normal range (35-45):
1. Tube dislodgement
2. Poor perfusion
3. Hyperventilation / Hypoventilation
Hyperventilation
CHILD BIRTH
Indications:
CPAP
Clinical indications:
CPAP is indicated in patients for whom inadequate ventilation is suspected. This could be as
a result of pulmonary edema, pneumonia, COPD, asthma, etc.
First-line access for all cardiac arrests Pt with an available secure IV line adequate for
Any ALS patient from whom immediate fluid or necessary treatment or in whom an IV line can be
medication treatment is indicated. In addition, placed in a timely fashion.
patients must have at least one of the following Pt’s that do not require immediate fluid or
1. Altered mental status medication therapy. IO SHALL NOT BE
2. Respiratory compromise PERFORMED FOR PROPHYLAXIS.
3. Hemodynamic instability Fracture of bone selected for IO infusion.
Inability to identify landmarks for procedure.
Known previous orthopedic procedure or
preexisting medical disease (such as tumor of the
bone selected for IO infusion.
Severe Burn or infection at the site of insertion.
1. Prepare Equipment
2. Select insertion site
a. Adult proximal humerus (PREFERRED SITE)
b. Adult proximal tibia: Measure one finger width distal to tibial tuberosity, along,
along the flat aspect of the medial tibia.
c. Pediatric proximal tibia: One finger width distal to the tibial tuberosity OR if unable
to palpate tibial tuberosity; two fingers below the patella along the flat aspect of
the medial tibia.
d. Adult distal tibia: Two finger widths proximal to the medial malleolus and midline
on the medial shaft.
e. Pediatric distal tibia. One finger width proximal to the medial malleolus along the
flat aspect of the medial distal tibia.
3. Prepare the skin with alcohol and/or betadine.
4. Prepare IO driver and needle set; load needle set onto driver.
5. Hold the IO driver in one hand and stabilize the leg near the insertion site with the opposite
hand.
6. Position the driver at the insertion site with the needle at a 90 Degree angle to the surface of
the bone.
7. Before powering the driver, insert the needle through the skin. When you feel the needle is
hitting resistance from the bone, make sure the 5mm line is still visible above the skin.
Power the driver on while applying minimal pressure. Insert the needle until a change in
resistance is noted. Remove the driver from the needle set and the stylet from the catheter.
Attach the connection tubing.
8. Use syringe to rapidly infuse 10ml of NS. If no infiltration is seen, attach the IV line and infuse
fluids or medications as usual. (For adults the IV bag will need to be under pressure.)
9. Secure the needle by looping the tubing and taping it back to the skin.
Flow Rate may appear to be slower than those achieved with an IV catheter
Ensure the administration of appropriate syringe bolus prior to infusion. NO FLUSH =NO FLOW
Pain control for EZ-IO Insertion should be performed prior to initial syringe flush or infusion. Allow to work for
30-60 seconds prior to Syringe flush
o For adults administer 40mg of Lidocaine = 2ml of 2% lidocaine for cardiac use.
o For pediatric s administer 0.5 MG/KG= 0.05 ml/kg of 2% lidocaine for cardiac use. (20 kg child = 1 mL)
Be cautious of potential air embolism, subcutaneous infiltration, fracture, or osteomyelitis.
Used to prepare patients with suspected spinal fracture for extrication and / or movement
from a sitting to a supine position.
When a short spine board could not be used.
1. Open KED and place it between the patient’s buttocks and the seat the
patient is sitting on.
2. Center the KED on the patient and position the KED snugly under the
patient’s armpits.
3. Fasten the chest straps, snug up the bottom and the middle straps.
4. Slide the leg straps under the patient’s legs, and around the tops.
5. Secure the leg straps to the same side of the KED.
1. Both rescuers grasp the side handles on opposite sides of the KED. Place
other arms under the patient’s legs.
2. Locking their arms together under the patient, the rescuers lift the patient
up (keeping the patients legs at a 45 degree angle).
3. Lower the patient onto the long spine board.
4. Undo the leg straps.
1. Apply a water-based lubricant to the beveled distal tip and posterior aspect of
the tube, taking care to avoid introduction of lubricant in or near the ventilatory
openings.
2. Position the head. (The ideal position for insertion is the “sniffing position”.
3. Hold the KING TUBE at the connector with the dominant hand. Hold the mouth
open with the non-dominant hand.
4. With the king tube rotated laterally 45-90 degrees such that the blue orientation
line is touching the corner of the mouth, introduce the tip into the mouth and
advance behind base of the tongue. NEVER FORCE THE TUBE INTO POSITION.
5. As tube tip passes under the tongue, rotate tube back to midline.
6. Without excessive force, advance KING tube until proximal opening of gastric
access lumen is aligned with the teeth or gums.
7. Inflate the KING tube using the volume of air indicated by the manufacture.
8. Attach BVM to the King Tube, and gently ventilate the patient.
9. Check for chest rise; auscultate the epigastric area for absence of abdominal
sounds, and the lungs bilaterally for breath sounds. (If successful continue to
ventilate patient).
10. Secure the KING-tube using an appropriate method.
Contraindications:
OROTRACHEAL INTUBATION
Clinical indications:
Inability to adequately ventilate a patient with a Bag Valve Mask or longer EMS transport
distances requiring a more secure airway.
An unconscious patient without a gag reflex who is apneic or is demonstrating inadequate
respiratory effort.
2. Properly position the patient in the supine position and ventilate adequately as indicated by the
patient treatment protocol you are following.
3. With suction standing by and proper manpower to provide Slicks maneuver if indicated, take
the laryngoscope in your LEFT hand and insert into the RIGHT side of the patients mouth. In a
forward abducting motion pull the lower jaw up and away from the patient while moving the
laryngoscope blade to the LEFT in an attempt to visualize the glottic opening. When you see the
glottic opening and can identify the landmarks of the glottic opening, insert the ETT through the
glottic opening and into the trachea until you are at approximately at 23-26cm at the lip line.
4. Ventilate the patient while checking for the standard "Earmarks" of a successful intubation,
those being:
o Good waveform on ETCO2 monitor (MOST RELIABLE INDICATOR)
o Condensation in the ETT
o Chest rise and fall
o Good BVM compliance
o Good positive and equal breath sounds
o Good gas exchange as indicated by the color change on the gas indicator
o Negative gastric sounds
5. Advise the receiving ER of an intubated patient and transport A.S.A.P. during protocol.
6.
Secure ET be
Do not Tube
puttooff
the patients
task face, using
by vomitus, in the“tube tamer”,
absence tape, or
of suction string. if you lift a little
sometimes
higher you can see over the top of the vomit into the back of the oropharynx.
If at all possible the patient should be placed on cardiac monitor at all times, to monitor for
bradycardia and cardiac rhythm.
Limit attempts to 10sec each.
NEEDLE DECOMPRESSION
Indications:
Tension Pneumothorax
Contraindications:
NEEDLE DECOMPRESSION
SPINAL IMMOBILIZATION
INDICATIONS:
NOTE: for the patients in a vehicle or otherwise unable to be place in the prone
or supine position, place them on a backboard by the safest method available
that maximizes maintenance of in-line spinal stability.
Contraindications:
Some patients due to size or age will not be able to be immobilized through in-line
stabilization with standard backboards and c-collars.
See the spinal motion restriction protocol for alternate methods of partial immobilization.
1. Stabilize the skin around the barb and use one hard jerk
to pull the barb out of the patient’s skin.
2. Ensure that the barb tips are intact.
3. Return Barbs to LEO. IF LEO does not take custody of the
barbs, dispose of them in a sharps container.
4. Provide proper wound care, clean and cover with a
bandage.
5. Inform patient and LEO that the patient will need to seek
medical attention if signs of infection later develop.
6. The subject will need a tetanus shot if they have not had
one in the last 10 years.
INJECTION: SUBCUTANEOUS
INTRAMUSCLAR
Clinical Indications:
When medication is necessary and the medication is necessary and the medication must be
given via SQ (not auto –injector) or IM route or as an alternative route in selected
medications
The thigh should be used for injections in pediatric patients and injection volume should not
exceed 1cc.
The most common site for subcutaneous injection is the arm
o Injection volume should not exceed 1cc.
The possible injection sites for subcutaneous injection include the arm, buttock, and thigh.
o Injection volume should not exceed 1cc for the arm.
o Injection volume should not exceed 2 cc for the thigh or buttock
INJECTION: SUBCUTANEOUS
INTRAMUSCLAR
1. Apply a water-based lubricant to the beveled distal tip and posterior aspect of
the tube, taking care to avoid introduction of lubricant in or near the ventilatory
openings.
2. Position the head. (The ideal position for insertion is the “sniffing position”.
3. Hold the KING TUBE at the connector with the dominant hand. Hold the mouth
open with the non-dominant hand.
4. With the king tube rotated laterally 45-90 degrees such that the blue orientation
line is touching the corner of the mouth, introduce the tip into the mouth and
advance behind base of the tongue. NEVER FORCE THE TUBE INTO POSITION.
5. As tube tip passes under the tongue, rotate tube back to midline.
6. Without excessive force, advance KING tube until proximal opening of gastric
access lumen is aligned with the teeth or gums.
7. Inflate the KING tube using the volume of air indicated by the manufacture.
8. Attach BVM to the King Tube, and gently ventilate the patient.
9. Check for chest rise; auscultate the epigastric area for absence of abdominal
sounds, and the lungs bilaterally for breath sounds. (If successful continue to
ventilate patient).
10. Secure the KING-tube using an appropriate method.
Contraindications:
TOURNIQUET
Clinical Indications:
Contraindications:
Non-extremity hemorrhage
Proximal extremity location where tourniquet application is not practical.
TRACTION SPLINT
Clinical Indications:
Padding can be placed in the patients groin to add to the patients comfort when possible.
Contraindications:
Pelvic fracture
If positioning the traction splint would delay the transport in a trauma patient in imminent
risk of circulatory collapse.
OROTRACHEAL INTUBATION
Clinical indications:
Inability to adequately ventilate a patient with a Bag Valve Mask or longer EMS transport
distances requiring a more secure airway.
An unconscious patient without a gag reflex who is apneic or is demonstrating inadequate
respiratory effort.
2. Properly position the patient in the supine position and ventilate adequately as indicated by the
patient treatment protocol you are following.
3. With suction standing by and proper manpower to provide Slicks maneuver if indicated, take
the laryngoscope in your LEFT hand and insert into the RIGHT side of the patients mouth. In a
forward abducting motion pull the lower jaw up and away from the patient while moving the
laryngoscope blade to the LEFT in an attempt to visualize the glottic opening. When you see the
glottic opening and can identify the landmarks of the glottic opening, insert the ETT through the
glottic opening and into the trachea until you are at approximately at 23-26cm at the lip line.
4. Ventilate the patient while checking for the standard "Earmarks" of a successful intubation,
those being:
o Good waveform on ETCO2 monitor (MOST RELIABLE INDICATOR)
o Condensation in the ETT
o Chest rise and fall
o Good BVM compliance
o Good positive and equal breath sounds
o Good gas exchange as indicated by the color change on the gas indicator
o Negative gastric sounds
5. Advise the receiving ER of an intubated patient and transport A.S.A.P. during protocol.
6.
Secure ET be
Do not Tube
puttooff
the patients
task face, using
by vomitus, in the“tube tamer”,
absence tape, or
of suction string. if you lift a little
sometimes
higher you can see over the top of the vomit into the back of the oropharynx.
If at all possible the patient should be placed on cardiac monitor at all times, to monitor for
bradycardia and cardiac rhythm.
Limit attempts to 10sec each.
TRANSFERS - TRAUMA
TRANSFERS - TRAUMA
TRANSFERS - TRAUMA
7. If the ventilator fails to work properly at any point during the transport of a
patient, IMMEDIATELY DISCONNECT THE VENTILATOR FORM THE PATIENT
AND SWITCH TO A BVM
Etomidate 20 mg IV 139
Pedi 0.3 mg/kg
Rocuronium 50 mg IV 155
Pedi 1 mg/kg
Vecuronium 10 mg IV 158
Pedi 0.1 mg/kg
ADENOSINE (ADENOCARD)
Class
Antiarrhythmic
Mechanism of Action
An endogenous purine nucleotide that slows conduction through the AV node,
interrupts the reentry pathways to the AV node and can restore normal sinus
rhythm in PSVT via modulation of K+ currents and blunting of catecholamine
response
Indications
Conversion to sinus rhythm of Paroxysmal Supraventricular Tachycardia
(PSVT), including that associated (Wolff-Parkinson-White syndrome)
To aid in the diagnosis of broad or narrow complex supraventricular
tachycardia
Protocol: Supraventricular Tachycardia
Contraindications
Hypersensitivity to the medication
2nd or 3rd degree AV block (except in patients with a functioning artificial
pacemaker)
Sick Sinus Syndrome where you see the accessory pathway conduct the atrial
impulses at rates > 220)
Adverse Reactions
Non-cardiac: facial flushing, chest pain, dyspnea, headache, lightheadedness
Cardiac: 1st, 2nd or 3rd degree heart block; transient asystole; varied atrial
and ventricular arrhythmias
1/2 life is 10 seconds. A brief period of asystole (up to 15 seconds) following
conversion, followed by resumption of NSR is common after rapid
administration
Adverse reactions are generally transient, resolve within 1 minute of
drug administration, and do not require intervention, nor are they an
indication to not attempt a subsequent administration of a higher dose of
the same medication.
Adult:
6mg FIVP with 10cc NS flush, wait 1-2 min if no conversion 12mg FIVP with
10cc NS flush , wait 1-2 minutes if no conversion 12mg FIVP with 10cc NS
flush (Max of 30mg)
Pediatric:
0.1 mg/kg (to a max of 6 mg) IV/IO with 10cc NS flush, wait 1-2 minutes.
If no conversion, 0.2 mg/kg (to a maximum of 12 mg) with a NS 10 ml flush.
Wait 1-2 minutes; if no conversion, 0.2 mg/kg (to a max of 12 mg) with a 10cc NS flush
(Total Max of 30mg)
1. Assemble equipment
a. Betadine prep swabs
b. Scalpel
c. Large curved hemostat, Bougie Tube, or Extra scalpel handle
d. Tracheostomy or endotracheal tube
e. Tape
2. Expose the neck.
3. Identify the thyroid cartilage. The space between the cricothyroid notch and the
thyroid cartilage is the location of the cricothyroid membrane.
4. Prep the area.
5. Stabilize the trachea by holding the thyroid cartilage between the thumb and
fingers.
6. Make a horizontal incision approximately ½ inch through the skin and cricothyroid
membrane.
7. Insert hemostat to dilate the incision. (Never remove scalpel or hemostat without
something in the incision space; the small incision will close.)
8. Turn the hemostat or scalpel handle until the opening is sufficient to allow the
passing of a small endotracheal tube. (6.0-7.0 mm
9. Pass the endotracheal tube about 1 – 1.5 inches into the trachea.
10. Inflate the cuff if using a cuffed tube and ventilate the pt with high flow oxygen.
11. Check breath sounds bilaterally and secure with tape.
12. Monitor patient condition and reassess frequently.
13. Control any bleeding and dress the wound.
TOURNIQUET
Clinical Indications:
Contraindications:
Non-extremity hemorrhage
Proximal extremity location where tourniquet application is not practical.
TRACTION SPLINT
Clinical Indications:
Padding can be placed in the patients groin to add to the patients comfort when possible.
Contraindications:
Pelvic fracture
If positioning the traction splint would delay the transport in a trauma patient in imminent
risk of circulatory collapse.
Cefazolin (Ancef)
Class
Antibiotic - cephalosporin
Mechanism of Action
Bactericidal agent that acts by inhibition of bacterial cell wall synthesis
Indications
Open Skeletal fracture
A break in the skin over a fracture site
Contraindications
History of anaphylaxis (not a simple rash) to penicillin
Known allergy to the cephalosporin group of antibiotics
<1 year of age
Adverse Reactions
Diarrhea
Anaphylaxis
Itching
Skin rash
Dosage and Administration
Adult:
1-2 gram IV infusion over 10-30 minutes
Can administer 1 gram for patient <70kg
Can administer 2grams for patients >70kg
After reconstituting medication, mix into a 50ml, 100ml or 250ml bag of Normal
Saline
Preferred mixing dose is 50ml Normal saline for each 1mg of
antibiotic
Duration of Action
Duration unknown
Special Considerations/Drug Interactions
Be alert for hypersensitivity reaction
Pregnancy Category B
Renal Impairment may require reduced dosage
IV incompatible with Amiodarone
Parenteral drug products should be shaken well when reconstituted and inspected
for particulate matter prior to administration
Note that reconstituted solutions may range in color from pale yellow to yellow
without a change in potency.
DILTIAZEM (CARDIZEM)
Class
Benzothiazepine, Calcium Channel Blocker, Cardiovascular agent
Mechanism of Action
A slow calcium channel blocker that blocks calcium ion influx during depolarization
of cardiac and vascular smooth muscle. It decreases peripheral vascular resistance
and caused relaxation of the vascular smooth muscle resulting in a decrease of both
systolic and diastolic blood pressure
Indications
Atrial arrhythmia
Protocol: Atrial Fibrillation
Contraindications
Administration of intravenous beta-blockers within a few hours of intravenous
Diltiazem
Atrial fibrillation or flutter associated with an accessory bypass tract (Wolff-
Parkinson- White or short PR syndromes)
Hypotension
Sick sinus syndrome without a pacemaker
Adverse Reactions
Bradyarrhythmia
Peripheral edema
CHF
Heart block
Myocardial infarction
Dosage and Administrations
Adult:
10-20mg SIVP over 2 min
May repeat with a dose of 25mg SIVP over 2 min
Duration of Action
Onset: 2-5 minutes
Special Considerations/Drug Interactions
Renal impairment can cause an increased risk of toxicity
Ventricular function, impaired
Hepatic or renal impairment, heart failure
DIPHENHYDRAMINE (BENADRYL)
Class
Antihistamine
Mechanism of Action
Antihistamines prevent histamines from reaching H1- and H2-receptor sites.
Antihistamine is specific for conditions in which histamine excess is present (for
example, acute urticaria) but is adjunctive therapy in the treatment of anaphylactic
shock because epinephrine is more effective.
Indications
Allergic reactions
Anaphylaxis
Acute dystonic reactions
Protocol: Overdose, anaphylaxis, excited delirium
Contraindications
Lower respiratory diseases such as asthma attacks
Patients taking MAOIs
Hypersensitivity
Narrow-angle glaucoma
Adverse Reactions
Dose-related drowsiness
Disrupted coordination
Hypotension
Palpitations
Tachycardia, bradycardia
Thickening of bronchial secretions
Dosage and Administrations
Adult:
25-50 mg SIVP/ IM
Pediatric:
1mg/kg SIVP/IM Max 25mg
Duration of Action - Diphenhydramine
Peak: 1-3 hours
Duration:6-12 hours
Special Considerations/Drug Interactions
CNS depressants may increase depressant effects.
MAOIs may prolong and intensify Anticholinergic effects of antihistamines.
DEXTROSE 50%
Class
Carbohydrate , hypertonic solution
Mechanism of Action
The term dextrose is used to describe the six-carbon sugar d-glucose, the principal
form of carbohydrate used by the body. D50 is used in emergency care to treat
hypoglycemia and to manage coma of unknown origin.
Indications
Hypoglycemia
Protocol: Diabetic emergencies
Contraindications
There are no significant contraindications for IV administration of 50% dextrose in
emergency care.
Adverse Reactions
Warmth
Pain and burning from medication infusion
Thrombophlebitis
Rhabdomyolysis
Dosage and Administrations
Adult:
25 g slow IV
Pediatric:
<1 mo AND < 45mg/dL D10 5mL/kg
1mo-12yr D25 2mL/kg
Duration of Action
Onset: < 1 minute
Special Considerations/Drug Interactions
Extravasations may cause tissue necrosis; use a large vein and aspirate occasionally
to ensure route patency.
D50 sometimes precipitates severe neurological symptoms (Wernicke's
encephalopathy) in thiamine-deficient patients such as alcoholics. (This can be
prevented by administering 100 mg of thiamine, IV.)
TRANSFERS - TRAUMA
ENALAPRILAT (VASOTEC)
Class
Enalaprilat is an angiotensin converting enzyme (ACE) inhibitor.
Mechanism of Action
Inhibition of ACE results in decreased plasma angiotensin II, which leads to
decreased vasopressor activity and to decrease aldosterone secretion.
Indications
Hypertension associated with Congestive Heart Failure (CHF)
Protocol: Congestive Heart Failure
Contraindications
Patients with a history of angioedema related to previous treatment with an
angiotensin converting enzyme inhibitor and in patients with hereditary or
idiopathic angioedema.
Hypersensitivity
Adverse Reactions
Angioedema (severe swelling of tongue, face, lips, throat)
Headache
Hypotension
Nausea
Dosage and Administrations
Adult: 1.25mg SIVP over 5 minutes, may repeat X1
Duration of Action
Onset: 15 minutes
Peak:1-4 hrs
Duration:4-6 hrs
Special Considerations/Drug Interactions
Use caution when administering to renal patients
May cause hyperkalemia
Enalaprilat may potentiate the effect of diuretics causing a significant decrease in
blood pressure
Lithium toxicity has been reported in patients receiving lithium concomitantly with
drugs which cause elimination of sodium, including ACE inhibitors
EPINEPHRINE (ADRENALINE)
Class
Sympathomimetic
Mechanism of Action
Epinephrine stimulates alpha-, beta1-, and beta2-adrenergic receptors in dose-
related fashion. It is the initial drug of choice for treating bronchoconstriction and
hypotension resulting from anaphylaxis as well as all forms of cardiac arrest. Rapid
injection produces a rapid increase in systolic pressure, ventricular contractility,
and heart rate. In addition, epinephrine causes vasoconstriction in the arterioles of
the skin, mucosa, and splanchnic areas and antagonizes the effects of histamine.
Indications
Bronchial asthma
Acute allergic reaction
Cardiac arrest
Anaphylaxis
Protocol: V-Fib/Pulseless V-Tach, Asystole/PEA, Anaphylaxis, COPD/Asthma,
Bradycardia
Contraindications
Hypersensitivity
Hypovolemic shock
Coronary insufficiency
Hypertension
Adverse Reactions
Headache, nausea, restlessness, weakness, dysrhythmias, hypertension
Dosage and Administrations
Adult:
V-Fib/Pulseless V-Tach, Asystole/PEA – 1mg (1:10,000) IV/IO every 3-5 minutes
Anaphylaxis – 0.3mg (1:1,000) IM every 5 minutes. May repeat x 1
COPD/Asthma - 0.3mg (1:1,000) IM. May repeat x 1 in 5 minutes.
Hypotension – 10 mcg q 3 minutes, or 5-20 mcg/min (calculated from normal
Dosage of 0.1-0.4 mcg/kg/min
Pediatric:
V-Fib/Pulseless V-Tach, Asystole/PEA – 0.01mg/kg (1:10,000) IV/IO every 3-5
minutes
Anaphylaxis – 0.01mg/kg (1:1,000) IM every 5 minutes, Max dose 0.3 mg. May
repeat x 2
Asthma - 0.01mg/kg (1:1,000) IM every 5 minutes. May repeat x 1
Bradycardia - 0.01mg/kg (1:10,000) IV/IO every 3-5 minutes
Duration of Action
Onset:
(SQ) 5-10 min (IV) 1-2 min
Duration: 5-10 min
TRANSFERS - TRAUMA
EPINEPHRINE NEBULIZED
Class
Sympathomimetic
Mechanism of Action
Acts as a bronchodilator that stimulates beta2 receptors in the lungs, resulting in
relaxation of bronchial smooth muscle. It alleviates bronchospasm, increases vital
capacity, and reduces airway resistance. It inhibits the release of histamine and is
useful in treating laryngeal edema.
Indications
Bronchial asthma
Prevention of bronchospasm
Croup (laryngotracheobronchitis)
Laryngeal edema
Protocol: Pediatric Respiratory Distress : Brochiolitis and Croup
Contraindications
Hypertension
Cardiovascular disease
Epiglottitis
Adverse Reactions
Tachycardia
Dysrhythmia
Dosage and Administrations
Pediatric:
Dilute 0.5ml of Epinephrine (1:1000) in 2.5ml of saline. Administer by
aerosolization
May repeat x 1 in 5 minutes.
Duration of Action
Onset : within 5 minutes
Duration : 1-3 hours
ETOMIDATE (AMIDATE)
Class
Etomidate is a hypnotic drug without analgesic activity
Mechanism of Action
Etomidate is a hypnotic drug without analgesic activity
Etomidate is a short-acting hypnotic, which appears to have gamma-aminobutyric
acid (GABA)–like effects. Unlike the barbiturates, etomidate reduces subcortical
inhibition at the onset of hypnosis while inducing neocortical sleep. Studies in
animals suggest that a part of the action of etomidate consists of a depression of the
activity and reactivity of the brain stem reticular formation.
Indications
Induction of general anesthesia
Protocol: Rapid sequence intubation, and post resuscitation induced hypothermia
Contraindications
Patients who have known hypersensitivity
Adverse Reactions
Etomidate may induce cardiac depression in elderly patients, particularly those with
hypertension
Transient venous pain on injection and transient skeletal muscle movements,
including myoclonus
Hyperventilation, hypoventilation, apnea of short duration (5 to 90 seconds with
spontaneous recovery), laryngospasm, hiccup and snoring. These conditions were
managed by conventional countermeasures.
Hypertension, hypotension, tachycardia, bradycardia and other arrhythmias have
occasionally been observed
Dosage and Administrations
Adult:
20 mg IV/IO
Pediatric:
0.3 mg/kg IV/IO, Max dose 20mg
FENTANYL
Class
Synthetic narcotic
Mechanism of Action
A potent, short-acting, rapid-onset opioid agonist that relieves pain by stimulating
opioid receptors in CNS; also causes respiratory depression and peripheral
vasodilation; inhibits intestinal peristalsis and sphincter of Oddi spasm; stimulates
chemoreceptors that cause vomiting; increases bladder tone.
Indications
Traumatic and Cardiac pain management, rapid sequence intubation
Protocol: rapid sequence intubation, pain management,
Contraindications
Hypersensitivity
Adverse Reactions
Bradycardia, more rapid and significant ventilation impairment in patients with
COPD and prolonged clinical effects in patients with hepatic or renal impairment.
Severe muscular rigidity develops in patients if administered rapidly.
Dosage and Administrations
Adult:
50-100mcg SIVP over 1-2 minutes; Max dose of 200mcg, May repeat X1
May be administered via IV/IM/IN
Pediatric:
1 mcg/kg SIVP over 1-2 minutes May repeat 1 mcg/kg X1
Duration of Action
Onset: Immediately (IV); 7 to 8 min (IM).
Duration: 30 to 60 min (IV); 1 to 2 h (IM).
Special Considerations/Drug Interactions
Amiodarone: Profound bradycardia, sinus arrest, and hypotension may occur.
Barbiturate anesthetics (e.g., thiopental) May have additive effects. Reduce
dosage of one or both agents.
CNS depressants (e.g., alcohol, benzodiazepines [e.g., diazepam], general
anesthetics, hypnotics, other opioid, phenothiazines, sedating antihistamines,
sedatives, skeletal muscle relaxants, tranquilizers) Concomitant use may
produce increased depressant effects (e.g., hypotension, profound sedation,
respiratory depression).
MAOIs (e.g., phenelzine) Fentanyl is not recommended for use in patients who
have received MAOIs within 14 days.
Geodon
Class
Antipsychotropic
Mechanism of Action
It has been proposed that Geodon’s beneficial effects are achieved by blocking
dopamine and serotonin receptors. Geodon also inhibits reuptake of serotonin and
epinephrine in the brain.
Indications
Psychosis where Excited Delirium is suspected.
Contraindications
Hypersensitivity to Geodon
Adverse Reactions
Prolonged Q-T Interval
Dosage and Administrations
Adult:
Excited Delirium: 10-20mg IM
Duration of Action
Onset: Within 1 min
Duration: 9-17 min
Special Considerations/Drug Interactions
Should not be given to patients with recent acute myocardial infarction, or known
history of QT prolongation.
Geodon should never be given intravenously.
IPRATROPIUM (ATROVENT)
Class
Anticholinergic (parasympatholytic) agent
Mechanism of Action
Atrovent inhibits interaction of acetylcholine at receptor sites on the bronchial
smooth muscle, resulting in bronchodilation
Indications
Patients with bronchospasm (asthma and COPD) may benefit from this medication.
Patients will typically present with wheezing or persistent cough. Remember with
severe bronchospasm, the patient may not be moving enough air to have lung
sounds auscultated
Protocol: COPD/Asthma
Contraindications
The solution that is used for nebulization can be safely used in patients with a soy
product allergy, but not if there is a known hypersensitivity to Ipratropium or
atropine.
Adverse Reactions
Palpitations
Dizziness
Anxiety
Tremors
Headache
Nervousness
Dry mouth
Dosage and Administrations
Adult:
0.5mg mixed with Albuterol via aerosolization x 3
Pediatric:
0.5mg mixed with Albuterol via aerosolization x 3
Duration of Action
Onset:5-15 minutes
Duration: 2-8 hrs
Special Considerations/Drug Interactions
Can cause a paradoxical bronchospasm increasing the patient's respiratory
difficulties.
Nebulizers can be attached to the ET tube and ventilated into patient with BVM.
LABETALOL
Class
Alpha- and beta-adrenergic blocker
Mechanism of Action
Labetalol is a competitive alpha1-receptor blocker as well as a nonselective beta-
receptor blocker used to lower blood pressure in a hypertensive crisis. Because of
alpha- and beta-blocking properties, blood pressure is reduced without reflex
tachycardia, and total peripheral resistance is decreased without a significant
alteration in cardiac output.
Indications
Hypertension
Protocol: Hypertension
Contraindications
Bronchial asthma
Congestive heart failure
Second- and third-degree heart block
Bradycardia
Cardiogenic shock
Adverse Reactions
Headache and facial flushing
Ventricular dysrhythmias
Hypotension and dizziness
Dyspnea
Diaphoresis
Dosage and Administrations
Adult:
10-20 mg SIVP over 2 min. Repeat X2 q 10 min
Duration of Action
Onset: Within 5 min
Duration: 3-6 hr
Special Considerations/Drug Interactions
Bronchodilator effects of beta-adrenergic agonists may be blunted by Labetalol.
Nitroglycerin may augment hypotensive effects.
Observe for signs of congestive heart failure, bradycardia, and bronchospasm.
Labetalol should only be administered with the patient in a supine position.
LIDOCAINE (XYLOCAINE)
Class
Antidysrhtythmic
Mechanism of Action
Lidocaine decreases phase-4 diastolic depolarization and suppresses premature
ventricular contractions. In addition, it is used to treat ventricular tachycardia and
some cases of ventricular fibrillation. Lidocaine also raises the ventricular
fibrillation threshold
Indications
Protocol: IO pain management
Contraindications
Hypersensitivity
Stokes-Adams syndrome
Second- or third-degree heart block in the absence of an artificial pacemaker
Adverse Reactions
Lightheadedness, hypotension, confusion, blurred vision, cardiovascular collapse,
bradycardia
CNS depression (altered level of consciousness, irritability, muscle twitching,
seizures) with high doses
Dosage and Administrations
Adult:
Intraosseous pain: 40 mg IV = 2 mL of 2% cardiac lidocaine
Pediatric:
Intraosseous pain: 0.5 mg/kg of 2% cardiac lidocaine
= 0.05 mL/kg,
10 kg = 0.5 mL, 20 kg = 1 mL, 30 kg = 1.5mL
Duration of Action
Onset: 30-90 sec
Duration: 2-4 hr
Special Considerations/Drug Interactions
Since Lidocaine is metabolized in the liver, elderly patients, patients with hepatic
diseases, shock or congestive heart failure will not break down the drug rapidly.
Consider one-half dose for boluses and drip rate in these patients.
Apnea induced with succinylcholine may be prolonged with large doses of
Lidocaine.
If bradycardia occurs in conjunction with PVCs, always treat the bradycardia first
with atropine or TCP. Exceedingly high doses of Lidocaine can result in coma or
death.
MAGNESIUM SULFATE
Class
CNS depressant
Mechanism of Action
Magnesium sulfate reduces striated muscle contractions and blocks peripheral
neuromuscular transmission by reducing acetylcholine release at the myoneural
junction.
Indications
Seizures of eclampsia (toxemia of pregnancy)
Torsade’s de pointes
Severe asthma
Protocol: Asthma, Eclamptic pregnancy
Contraindications
Heart block
Adverse Reactions
Diaphoresis
Facial flushing
Hypotension
Depressed reflexes
Hypothermia
Reduced heart rate
Circulatory collapse
Respiratory depression
Dosage and Administrations
Adult:
2 grams in 50 cc of NS over 10 minutes
Duration of Action
Onset: Immediate
Duration: 3-4 hr
Special Considerations/Drug Interactions
CNS depressant effects may be enhanced if the patient is taking other CNS
depressants.
Serious changes in cardiac function may occur with cardiac glycosides.
IV calcium gluconate or calcium chloride should be available as an antagonist to
magnesium if needed.
Magnesium must be used with caution in patients with renal failure, since it is
cleared by the kidneys and can reach toxic levels easily in those patients.
METHYLPREDNISOLONE (SOLU-MEDROL)
Class
Glucocorticoid
Mechanism of Action
Methylprednisolone is a synthetic steroid that suppresses acute and chronic
inflammation. In addition, it potentiates vascular smooth muscle relaxation by beta-
adrenergic agonists and may alter airway hyperactivity. A newer usage is for
reduction of posttraumatic spinal cord edema
Indications
Anaphylaxis
Bronchodilator for unresponsive asthma
Shock (controversial)
Acute spinal cord injury
Protocol: COPD/Asthma, Anaphylaxis
Contraindications
Use with caution in patients with, immuno-suppressed systems, GI bleeding and
diabetes mellitus.
Adverse Reactions
Headache
Hypertension
Sodium and water retention
Hypokalemia
Alkalosis
Dosage and Administrations
Adult:
125mg IV/IM
Pediatric:
2mg/kg IV/IM Max dose of 125 mg
Duration of Action
Onset: 1-2 hrs
Duration: 8-24 hr
Special Considerations/Drug Interactions
Crosses the placenta and may cause fetal harm.
Ensure that the patient is not currently ill (pneumonia) or is currently taking
steroids.
MIDAZOLAM (VERSED)
Class
Short-acting benzodiazepine CNS depressant
Mechanism of Action
Midazolam HCl is a water-soluble benzodiazepine that may be administered for
conscious sedation to relieve apprehension or impair memory before endotracheal
or nasotracheal intubation.
Indications
Premedication for tracheal intubation
Seizures
Protocols: Rapid sequence intubation, seizures, anxiety, behavioral, sedation prior
to cardioversion
Contraindications
Hypersensitivity to Midazolam
Glaucoma
Shock
Depressed vital signs
Concomitant use of barbiturates, alcohol, narcotics, or other CNS depressants
Adverse Reactions
Cough and/or hiccups
Over-sedation
Nausea and vomiting
Headache and/or blurred vision
Fluctuations in vital signs including hypotension
Respiratory depression and/ or arrest
Dosage and Administrations
Adult:
Anxiety: 1-2 mg IV/IM/IN
RSI: 5mg IV/IM/IN, May Repeat X 1
Seizures, behavioral: 5mg IN/IV/IM, May repeat x 1
Excited Delirium: 10 mg/IV/IM
Pediatric:
Seizures: 0.1 mg/kg IN/IV/IM Max 5mg
Sedation: 0.1mg/kg Max 2mg
Duration of Action
Onset: 1-3 min (IV); dose dependent
Duration: 2-6 hr; dose dependent
Special Considerations/Drug Interactions
Sedative effect of midazolam may be accentuated by concomitant use of
barbiturates, alcohol, or narcotics (it should therefore not be used in patients who
have taken CNS depressants).
Administer immediately before the intubation procedure.
MORPHINE SULFATE
Class
Opioid analgesic
Mechanism of Action
Morphine sulfate is a natural opium alkaloid that increases peripheral venous
capacitance and decreases venous return ("chemical phlebotomy"). It promotes
analgesia, euphoria, and respiratory and physical depression. Secondary
pharmacological effects of morphine include depressed responsiveness of alpha-
adrenergic receptors (producing peripheral vasodilation) and baroreceptor
inhibition. In addition, because morphine decreases both preload and afterload, it
may decrease myocardial oxygen demand.
Indications
Moderate to severe acute and chronic pain
Should be used with caution with pulmonary edema
Protocol: pain management
Contraindications
Hypersensitivity to narcotics
Diarrhea caused by poisoning
Hypovolemia
Hypotension
Adverse Reactions
Hypotension, tachycardia, bradycardia, palpitations, syncope, facial flushing,
respiratory depression, euphoria, bronchospasm, dry mouth
Dosage and Administrations
Adult:
2-5 mg every 5 minutes Max 10 mg
Pediatric
0.1 mg/kg Max 5mg
Duration of Action
Onset: Immediate
Duration: 2-7 hr
Special Considerations/Drug Interactions
CNS depressants may potentiate effects of morphine (respiratory depression,
hypotension, sedation).
MAOl’s may cause paradoxical excitation.
Narcotics rapidly cross the placenta. Use with caution in older adults, those with
asthma, and those susceptible to CNS depression. May worsen bradycardia or heart
block in inferior myocardial infarction (vagotonic effect). Naloxone should be
readily available.
NALOXONE (NARCAN)
Class
Synthetic opioid antagonist
Mechanism of Action
Naloxone is a competitive narcotic antagonist used in the management and reversal
of overdoses caused by narcotics and synthetic narcotic agents. Unlike other
narcotic antagonists, which do not completely inhibit the analgesic properties of
opiates, naloxone antagonizes all actions of morphine.
Indications
Decreased level of consciousness
Coma of unknown origin
For the complete or partial reversal of CNS and respiratory depression induced by
opioids: Narcotic agonist : Morphine sulfate, Heroin, Hydromorphone (Dilaudid),
Methadone , Meperidine (Demerol) , Paregoric, Fentanyl citrate (Sublimaze),
Oxycodone (Percodan), Codeine, Propoxyphene (Darvon)
Narcotic agonist and antagonist: Butorphanol tartrate (Stadol), Pentazocine
(Talwin), Nalbuphine (Nubain)
Protocol: Overdose
Contraindications
Hypersensitivity
Adverse Reactions
Tachycardia and/or dysrhythmias
Hypertension
Nausea and vomiting
Diaphoresis
Dosage and Administrations
Adult:
0.4mg IV/IM/IN, Max of 2 mg
Duration of Action
Onset: Within 2 min
Duration: 30-60 min
Special Considerations/Drug Interactions
Seizures have been reported (no causal relationship established).
May not reverse hypotension. Caution should be exercised when administering
naloxone to narcotic addicts (may precipitate withdrawal with hypertension,
tachycardia, and violent behavior).
NITROGLYCERIN
Class
Vasodilator
Mechanism of Action
It is now believed that atherosclerosis limits coronary dilation and that the benefits
of nitrates and nitrites result from dilation of arterioles and veins in the periphery.
The resulting reduction in preload and to a lesser extent in afterload decreases the
work load of the heart and lowers myocardial oxygen demand. Nitroglycerin is very
lipid soluble and is thought to enter the body from the GI tract through the
lymphatics rather than the portal blood.
Indications
Ischemic chest pain
Congestive heart failure(CHF)
Protocol: Acute coronary syndrome(ACS) , CHF
Contraindications
Hypersensitivity
Hypotension
Do not administer NTG to male patients who have taken medication for erectile
dysfunction in the previous 48 hours. The combination of these meds with NTG may
produce profound hypotension or cardiac arrest.
Adverse Reactions
Transient headache
Postural syncope
Reflex tachycardia
Hypotension
Nausea and vomiting
Muscle twitching
Diaphoresis
Dosage and Administrations
Adult:
ACS: 0.4 mg metered dose every 5 minutes until systolic BP of > 90
CHF: 0.4mg every 3 minutes x 5
Hypertension: 0.4mg X3
Duration of Action
Onset:1-3 min
Duration:20-30 min
Special Considerations/Drug Interactions
Nitroglycerin decomposes when exposed to light or heat.
NOREPINEPHRINE (LEVOPHED)
Class
Sympathomimetic
Mechanism of Action
Norepinephrine alpha- and beta1-adrenergic receptors in dose-related fashion. It is
the initial drug of choice for treating hypotension refractory to IV fluids in the
setting of sepsis. Continuous IV infusion results in increased contractility and heart
rate as well as vasoconstriction, thereby increasing systemic blood pressure and
coronary blood flow. Clinically, alpha effects (vasoconstriction) are greater than
beta effects (inotropic and chronotropic effects).
Indications
Hypotension refractory to 2L of IV fluids in the setting of sepsis
Protocol: Hypotension
Contraindications
Hypersensitivity
Hypertension
Adverse Reactions
Headache, nausea, restlessness, weakness, dysrhythmias, hypertension
Dosage and Administrations
Adult: Hypotension – 2-12 mcg/min
NOTE: NOT WEIGHT BASED INFUSION
Pediatric: Not used in prehospital setting due to need for extremely low
weight-based dose (0.05-0.1 mcg/kg/min)
Special Considerations/Drug Interactions
Now considered first line vasoactive agent for septic shock, as dopamine was found
in a large clinical trial to have an unacceptably high occurrence of dysrhythmias
Large doses have been described in clinical trials 0.01-3 mcg/kg/minute
(0.7 to 200 mcg/min)
ONDANSETRON (ZOFRAN)
Class
Antiemetic, Serotonin Receptor Antagonist, 5-HT3
Mechanism of Action
Antiemetic - The mechanism by which ondansetron works to control nausea and
vomiting is not fully understood; it is believed that the antiemetic properties occur as a
result of serotonin receptor antagonism.
Indications
Nausea and vomiting due to chemotherapy.
Prophylactic use prior to administration of pain management medication.
Nausea and vomiting with moderate to severe dehydration or electrolyte imbalance.
Protocol: nausea including nausea in a CVA patient
Contraindications
History of allergic reaction to ondansetron or to any medicine similar to ondansetron,
including dolasetron (Anzemet), granisetron (Kytril), or palonosetron (Aloxi).
Adverse Reactions
Constipation, diarrhea, dry mouth
Headache, dizziness, drowsiness/sedation
Anaphylaxis (rare)
Fatigue, malaise, chills
Cardiac dysrhythmia (rare), hypotension
Bronchospasm
Muscle pain
Dosage and Administrations
Adult:
4mg IV/IM, may repeat X1
Pediatric:
6 months to 4 years: 2 mg IV/IM
Greater than 4 years: 4 mg IV/IM
Duration of Action
Onset: Immediate
Duration 4-6 hours
Special Considerations/Drug Interactions
Patients with a history, or family history, of Long QT syndrome; transient EKG changes
have been seen with IV administration including QT interval prolongation.
ORAL GLUCOSE
Class
Monosaccharide Carbohydrate
Mechanism of Action
After absorption of glucose in the GI tract, glucose is distributed in the tissues and
provides a prompt increase in circulating blood sugar
Indications
Hypoglycemic conscious pt w/ altered mental status
Protocol: Diabetic emergencies
Contraindications
Unconscious
Patient hasn't taken insulin for days
Adverse Reactions
Nausea
Dosage and Administrations
Adult and Pediatric:
15 grams PO
SL Preferred method of administration is between the cheek and gums
Duration of Action
Onset: 15 minutes
Special Considerations/Drug Interactions
Assure patient has the capabilities of swallowing and maintaining an airway
Ensure that a BGL is checked prior to administration of Glucose in all patients,
especially ones that may have a suspected head injury
Reassess BGL after administration of Glucose
OXYGEN
Class
Naturally occurring atmospheric gas
Mechanism of Action
Oxygen is odorless, tasteless, colorless gas that is present in room air at a
concentration of about 21%. It helps oxidize glucose to produce ATP (Adenosine
triphosphate).
Indications
Confirmed or suspected hypoxia
Ischemic chest pain
Respiratory insufficiency
Prophylatically during air transport
Confirmed or suspected carbon monoxide poisoning and other causes of decreased
tissue oxygenation
Protocol: Universal treatment guidelines
Contraindications
Oxygen should not be withheld from any patients, even those with COPD.
Adverse Reactions
High flow oxygen may cause decreased LOC and respiratory depression in patients
with COPD
Dosage and Administrations
Adult and Pediatric:
High concentration: 10-15 lpm via nonrebreather mask
Low concentration: 1-4 lpm via nasal cannula
Nebulizer: 8 lpm
Duration of Action
Onset: Immediate
Duration: less than 2 minutes
Special Considerations/Drug Interactions
Oxygen vigorously supports combustion
ROCURONIUM
Class
Non depolarizing neuromuscular blocker
Mechanism of Action
Rocuronium bromide is a non-depolarizing skeletal muscle relaxant. Binding with
cholinergic receptor sites inhibits transmission of nerve impulses, antagonizing the
action of acetylcholine. Has no analgesic properties and the patient maybe conscious,
but unable to communicate by any means.
Indications
To maintain complete muscle relaxation with an intubated patient
Protocol: rapid sequence intubation
Contraindications
Hypersensitivity
Adverse Reactions
Causes respiratory paralysis; supportive airway control must be continuous and under
direct observation at all times.
Dosage and Administrations
Adult:
50mg IV
Pediatric:
1mg/kg (max 50mg)
Duration of Action
Onset: 1-2 minutes
Peak: 4 minutes
Duration: 30 minutes
Special Considerations/Drug Interactions
Myasthenia gravis and other neuromuscular diseases increase sensitivity to the drug.
SODIUM BICARBONATE
Class
Buffer
Mechanism of Action
Sodium bicarbonate reacts with hydrogen ions to form water and carbon dioxide
and thereby can act to buffer metabolic acidosis. Increasing the plasma
concentration of bicarbonate causes blood pH to rise.
Indications
Tricyclic antidepressant (TCA) overdose
Alkalinization for treatment of specific intoxications
Protocol: Hyperkalemia, Crush injury
Contraindications
In patients with chloride loss from vomiting and Gl suction
Metabolic and respiratory alkalosis
Hypocalcemia
Hypokalemia
Adverse Reactions
Metabolic alkalosis
Hypoxia
Rise in intracellular Pco2 and increased tissue acidosis
Electrolyte imbalance (tetany)
Seizures
Tissue sloughing at injection site
Dosage and Administrations
Adult:
Hyperkalemia/Crush injury: 50- 100mEq
TCA: 50-100 mEq
Duration of Action
Onset: 2-10 min
Duration: 30-60 min
Special Considerations/Drug Interactions
May precipitate in calcium solutions.
Vasopressors may be deactivated.
Bicarbonate administration produces carbon dioxide, which crosses cell membranes
more rapidly than bicarbonate, potentially worsening intracellular acidosis.
May increase edematous or sodium-retaining states.
May worsen congestive heart failure.
THIAMINE
Class
Vitamin (B1)
Mechanism of Action
Thiamine combines with ATP to form thiamine pyrophosphate coenzyme, a
necessary component for carbohydrate metabolism. Most vitamins required by the
body are obtained through diet, but certain states, such as alcoholism and
malnourishment, may affect the intake, absorption, and use of thiamine. The brain is
extremely sensitive to thiamine deficiency.
Indications
Coma of unknown origin (before the administration of dextrose 50%, or Naloxone)
Delirium tremens
Beriberi (rare) / Wernicke's encephalopathy
Protocol: Diabetic emergencies
Contraindications
There are no significant drug interactions with other emergency medications
Adverse Reactions
Hypotension (from rapid injection or large dose)
Anxiety
Diaphoresis
Nausea and vomiting
Allergic reaction (usually from IV injection; very rare)
Dosage and Administrations
Adult: 100mg IV/IM
Duration of Action
Onset: Rapid
Duration: variable
Special Considerations/Drug Interactions
Large IV doses may cause respiratory difficulties.
Anaphylactic reactions have been reported.
VECURONIUM
Class
Non depolarizing neuromuscular blocker
Mechanism of Action
Vecuronium bromide is a non-depolarizing skeletal muscle relaxant. Binding with
cholinergic receptor sites inhibits transmission of nerve impulses, antagonizing the
action of acetylcholine. Has no analgesic properties and the patient maybe conscious,
but unable to communicate by any means. First muscles affected include eyes, face,
neck; followed by limbs, abdomen, chest; diaphragm affected last. Recovery usually
occurs in the reverse order and may take longer than 60 minutes.
Indications
To maintain general anesthesia with an intubated patient
Protocol: rapid sequence intubation
Contraindications
Hypersensitivity
Adverse Reactions
Causes respiratory paralysis; supportive airway control must be continuous and under
direct observation at all times.
Dosage and Administrations
Adult:
10mg IV
Pediatric:
0.1mg/kg (max 10mg)
Duration of Action
Onset: 30-60 seconds
Peak: 3-5 minutes
Duration: 30-60 minutes
Special Considerations/Drug Interactions
Myasthenia gravis and other neuromuscular diseases increase sensitivity to the drug.
( ) Foil Blanket - 1
( ) Burn Sheet - 2 MEDICATIONS
( ) Trauma Dressing – 2 MEDICATIONS
( ) Abdominal Pads - 2 KIT UNIT
( ) Alcohol Preps – 1 bx KIT UNIT
( ) Iodine Preps – 3 Activated Charcoal 50g [ ] x 1
( ) Band Aids – 1 bx [ ] x 1 Solu-Medrol 125mg []x1
( ) Bacitracin – 5 pk [ ] x 5 Adenosine 6mg [ ]x5
( ) Tape – 1” – 4 [ ] x 1 Succinylcholine 200mg [ ] x 1
( ) Paper Tape - 1 [ ] x 3 Albuterol 2.5mg [ ]x6 (Keep in cooler if available)________
( ) Sterile Water - 2
( ) Rubbing Alcohol - 1 [ ] x 2 Amiodarone 150mg [ ]x4 [ ] x 1 Thiamine 200mg []x1
( ) Triangular Bandages - 4
( ) Kerlix – 4 Ancef (Cefazolin) 1g [ ]x2 [ ] x 1 Vecuronium 10mg or [ ]x1
( ) Ace Wrap – 2 Rocuronium 100mcg [ ] x1
( ) Commercial Tourniquet - 1 [ ] x 1 Aspirin 81mg - 1 btl [ ]x1 (Keep In cooler if available_________)
( ) Occlusive Dressing - 4
( ) 4x4 Sterile – 1 bx [ ] x 3 Atropine 1mg [ ]x3
( ) 4x4 Non sterile – 1 pk
( ) Cold packs- 5 [ ] x 1 Dextrose 50% 25g [ ]x1
( ) Hot Packs – 5
( ) Trauma Shears – 1 [ ] x 1 Diltiazem 25mg [ ]x2
( ) Ring Cutter - 1 (Keep in cooler if available)________
( ) Glucometer Strips – 10
( ) Lancets – 6 [ ] x 1 Diphenhydramine 50mg [ ] x 1
( ) Ammonia Inhalants – 5
( ) Select 3 – 6 [ ] x 1 Calcium Gluc. 10ml [ ]x1
( ) Buretrol set – 1
( ) Dial-a-flow-1 [ ] x 1 Enalaprilat 2.5mg [ ]x1
( ) Saline 10cc vial/syringe – 10
( ) Saline 50cc bag – 2 [ ] x 1 Epinephrine (1:1) 1mg [ ] x 1
( ) Saline 250cc bag – 2
( ) Saline 500 or 1000cc bag – 6 [ ] x 6 Epinephrine (1:10) 1mg [ ] x 6
( ) IV catheter (16, 18, 20) -6 ea
( ) IV catheter (22, 24) – 2 ea [ ] x 1 Etomidate 20mg [ ]x1
( ) Needle 20ga – 5
( ) IO 15ga – 1 [ ] x 1 Glucose Oral 15g [ ]x1
( ) Syringe 1cc- 2
( ) Syringe 3 cc – 5 [ ] x 2 Ipratropium 0.5 mg [ ]x3
( ) Syringe 10cc – 10
( ) Syringe 30cc – 2 [ ] x 1 Labetalol 40mg [ ]x1
( ) Sharps Container Lg – 1
( ) Sharps Container Sm – 1 [ ] x 1 Lidocaine 2% 100mg [ ]x1
( ) Biohazard Bags – 2
( ) Trash Bags – 2 [ ] x 2 Magnesium Sulfate 1g [ ]x2
( ) N95 Mask – 4
( ) Gowns- 4 [ ] x 1 Narcan 2mg [ ]x1
( ) Safety Glasses- 3
( ) Gloves (Sm, Med, Lg, X-Lg) -1bx [ ] x 1 Nitroglycerin Spray Btl [ ] x 1
( ) Hand Sanitizer – 1
( ) Cavicide Wipes/Spray- 1 [ ] Norepinephrine 4mg [ ] x2
( ) Thermometer
( ) Peroxide-1 btl [ ] x 1 Ondansetron 4mg [ ]x2
( ) stuffed animal x2
[ ] Labetalol 40mg x 1
[ ] Lidocaine 2% 100mg x 1
[ ] Magnesium Sulfate 1g x 4
[ ] Narcan 2mg x 1
[ ] Ondansetron 4mg x 2
[ ] Solu-Medrol 125mg x 1